Saturday November 21 2009 | Biotechnology feed | All feeds
Have your press releases posted here? BioPortfolio Client Press ReleasesCytotoxics remain standard bearers The Board of International Biotechnology Trust Plc (“IBT”) today announces its unaudited Annual Results for the twelve months ended 31 August 2005 MOUSE GENES OFF THE SHELF Geneservice and RZPD to distribute DNABookTM York Pharma founds Japanese operating company and appoints President Epitan Completes Recruitment and Dosing for Photoprotection Trial in Sydney IMMUTEP Appoints Michel Greco To Board Of Directors SR Pharma: Interim results for the six months ended 30 June 2005 Pioneer of drug discovery data management software recognized for his contribution to the industry IDBS launches ActivityBase XE – revolutionary solution for high throughput screening data management Apollo grows with acquisition $60 billion of pharmaceutical company revenues under threat from generic drugs LifePharms, Inc. Receives Approval for Phase II SBIR Grant for Cancer Research from NIH Lipoxen announces collaboration agreements with Baxter Healthcare & two other biopharmaceutical companies Epitan begins PMLE trial in Melbourne Singvax And Octoplus Announce Collaboration To Develop Single-Shot Japanese Encephalitis Vaccine CellCentric and Cancer Research Technology initiate co-development partnership GM food avoidance policies to become more expensive, according to new report RNTECH & DNAVision Announce A Co-Marketing Agreement To Offer A Complete Solution For Biomarker And Target Discovery In Oncology York Pharma appoints new Chairman Launch of East Midlands bioscience knowledge exchange initiative Millipore and Oxford Immunotec Co-develop Plates for Diagnosing and Monitoring Infections G-BOX, a New Concept in Image Analysers Offers the World’s First Affordable Custom Designed System Cytheris launches a new Phase I clinical trial in the US for its recombinant Interleukin-7 DE NOVO LAUNCHES REFLEX, A MAJOR UPGRADE TO ITS IN SILICO DRUG DESIGN PLATFORM Novagali Pharma completes a Phase I clinical trial in oncology with its oral formulation of Paclitaxel Eyes turning to Neuropathic pain market New Order for Biacore®A100 Received from Major Pharmaceutical Company ViRexx completes $4 million private placement Phase I ProCord Study Results Published in the Journal of Neurosurgery: Spine September 2005 Issue Agilent Technologies launches ChIP-on-chip microarray platform, enabling researchers to analyze gene regulation Drug Safety in the Post-Vioxx Era Antibacterial hope lies in clever drugs for superbugs M&A is not the only way Merck & Co - Amrad: an uncertain pathway to success Doubling up in battle to beat cholesterol Epitan receives ethics approval for Phase II PMLE trial at St Vincent's Hospital in Melbourne New vaccine offers better protection against pulmonary tuberculosis Bayer Selects InforSense for Next Generation Integrative Analytics Infrastructure - InforSense KDE to Provide Workflow-based Cheminformatics Platform P2i plan to extend pipette nano-coating success to other consumables and devices - Saving the very last drop Protagen AG - Powerful protein biochips for antibody development Liponex Develops Improved Formulation of CRD5 Oxford Biomedica Announces Appointment Of Chief Medical Officer Solexa And Collaborating Scientists Illuminate The Small RNA Component Of The Transcriptome BioPlanta GmbH and AnalytiCon Discovery GmbH announce their cooperation in the plant-based search for active ingredients Dnavision Is The First European Pharmacogenomic Service Laboratory To Succeed Iso/Iec 17025 Audit Northbank Communications strengthens team with two new staff additions CellCentric receives new funding from NESTA to further its work in epigenetics and cancer Innate Pharma obtains ISO9001:2000 certification for its research and development activity in the field of immunotherapy Evolva Acquires Pharmaceutical Business of Poalis York Pharma founds UK commercial operations unit and appoints Sales & Marketing Director BioPortfolio BioNewsCast Client Press Releases 2005 ArchiveBioPortfolio BioNews (News & Press Releases) August 2005Apollo's human-expressed Interleukin 2 six times more active than competitor Affymetrix Dominates DNA Microarrays Market Ablynx Successful In Maintaining Key Claims After Nanobody™ Patent Challenge New Proteomics Software - Promises Quick and Easy Identification of Biologically Relevant Proteins InforSense and National Cancer Institute Enter Five-year Agreement Physiomics announces appointment of David Evans as Chairman A New Generation of Bioinformatics Software - All Basic Research Tools Available Free of Charge Queen’s Award for Abcam highlights business success Novel Imaging Application of ChemiGenius2 Is Helping with Vital Research into the Causes of Diabetes Related Blindness SYMPHOGEN AND CAMBRIDGE ANTIBODY TECHNOLOGY SIGN PATENT LICENSING AGREEMENT MIP Technologies Raises SEK 30 million (USD3.9M) World Renowned Geneticist David Bentley, D.Phil. Joins Solexa As Chief Scientist Cerenis Therapeutics Completes 25 Million Euros ($30.5 Million) Series A Financing To Progress Hdl-Related Drugs For Cardiovascular Diseases Peakdale share issue to staff exceeds expectations Diary Date-Genomes to Systems Conference 22-24 March Ablynx appoints Hennie Hoogenboom as Chief Scientific Officer Peakdale announces appointment of industry figurehead as Medicinal Chemistry Services Director Automated Colony Counters Help Monitor Air Quality To Provide a Healthier Living Environment West Pharmaceutical Services, Inc. to Acquire Medimop Medical Projects Ltd Peakdale launches 5th Class A GPCR library and announces plans to develop other GPCR class libraries Blue Membranes and Relisys Medical announce starting the International Multi Center Registry for the porous carbon/carbon composite coated Drug-Eluting Stent. Oxford Immunotec Closes £7m In Series B Financing Cobra and Auxilium Announce Extension of Agreement to Manufacture AA4500 for Auxilium Pharmaceuticals, Inc. West Pharmaceutical Services Appoints Mike Schaefers Director Of Marketing, Europe West Pharmaceutical Services Appoints Graham Reynolds Vice President, Reconstitution And Transfer Services Dowpharma Announces Additional Capabilities for Nucleic Acid Medicines Production Registration and poster submissions open for SCIpharm 2006 conference Northbank Communications Strengthens Team with Promotions and Staff Additions New motorised observation filter wheel for swift filter switching introduced by Olympus Aptanomics to validate targets and identify new druggable sites for Boehringer IngelheimBioPortfolio BioNews (News & Press Releases) July 2005SR Pharma announces £10m of new funding following a successful fundraising OXFORD BIOMEDICA SUCCESSFULLY COMPLETES STAGE ONE OF THE PHASE II TRIAL WITH METXIA IN PANCREATIC CANCER OXFORD BIOMEDICA IS AWARDED GRANT FOR MONUDIN® FROM THE MOTOR NEURONE DISEASE ASSOCIATION POWDERMED MANUFACTURES A VACCINE AGAINST H5N1 (AVIAN INFLUENZA) FOR CLINICAL DEVELOPMENT Microm Microtech France in drive for growth after management buy-out Inpharmatica Announces Chematica(TM) Collaboration with Tibotec Pharmaceuticals Ltd. New Report Examines Biotech Giant Amgen’s Success and Future Direction Brain cancer: glioblastoma incidence to pass 18,000 cases by 2015 Cancer therapy: clinical trials to trigger antihormonals market shift Scientists advance understanding of the role of a key brain protein in autism Following Inspection by UK Regulators, Cobra's Manufacturing Authorisation is extended Uncertainty reigns as biotech patents remain unharmonised Discover and understand unmet needs in the ADHD market A Tip for Better Pipetting: P2i surface enhancements for pipette tips reduce retention and open up other functional capabilities. MIP wins pyrethroid residue detection contract with US EPA Syngene's GeneGenius at Leading UK University Is Helping Accurately Detect Mutations in Microbial DNA Peakdale establishes in-house computational chemistry capabilities Blue Membranes closes its 2nd round financing after the technology buy-out in late 2003. Targeted Drug Delivery for Cancer Lab21 – a new kind of company Antiviral drug discovery services and clinical trials support Milestone in the development of Histone Deacetylase Inhibitors Capravirine discontinued, but Pfizer's HIV R&D won't stop The Pharmaceutical Market Outlook to 2015 Implementing innovative, long-term strategies for sustainable future growth Olympus Europe and MMI Molecular Machines & Industries announce exclusive distribution agreement BioInvent Interim Report 1 January-30 June 2005 Innate Pharma strengthens international management team by appointing Director of Business Development Eden Biodesign and Partnership for Learning to champion Inpharmatica launches Annotation Express(TM) Cytheris launches two new Phase I clinical trials for its recombinant Interleukin-7 AnalytiCon Discovery To Identify New Natural Compounds For Johnson & Johnson Pharmaceutical Research & Development Oxford Immunotec Prevails in Core Patent Dispute with Cellestis and Sanofi-Pasteur Cytomics Systems identifies new anti-cancer molecules targeting the Ubiquitin-proteasome pathway Daxas deal leaves Altana short of breath Dow Pharmaceutical Sciences Announces FDA Approval of METROGEL® (metronidazole) Topical Gel 1% for Rosacea Meditech Signs Collaboration Agreement with Hyalose Acolyte to Provide Life Sciences Applications for Adenylate Kinase Clinical trials catalyst for market shift Wageningen research brings allergen-free apple within reach ‘Plants for the Future’ programme sets a European agenda for the goals and benefits of plant genomics and biotechnology Danish biopharmaceutical company TopoTarget A/S successfully listed on Copenhagen Stock Exchange Morphochem and The Genetics Company: successful resolution of X-ray structure of ß-secretase with a novel inhibitor compound Oxford Biomedica Is Granted Key Lentivector® Patents In China Evolva and AnalytiCon enter Nuclear Receptor Alliance Haptogen directors win science and technology prize at Scotland Entrepreneur of the Year Awards 2005 BioPortfolio BioNews (News & Press Releases) June 2005Biotechnology Conference Announced - Silicon Alley Entrepreneurs Club (SAEC) to Host Biotech and Life Sciences Global Venture Congress 2005 at Madison Square Garden Qiagen and Invitrogen Revealed as Top Suppliers in the RNA Purification Market Artemis International Unveils Enhanced New Product Development Solution Artemis_International_1_files/filelist.xmlApollo Life Sciences Lists at 54% Premium KeyNeurotek AG announces exclusive licence agreement with Bayer Health-care AG Santaris Pharma raises EUR 4.4 million in interim funding from lead investors and launches second round financing InforSense Orchestrates Bioinformatics Services on Apple Workgroup Cluster Novel production of anti malaria drug ahead West Pharmaceutical Services Inc. Introduces Flip-Off CCS Seals for Aseptic Processing The FDA has requested a label change for AstraZeneca's Iressa, to be implemented in September 2005. UK-based healthcare technology provider iSoft has released strong full year financial results. Gilead initiates trial to evaluate HIV drug Pfizer begins drug production in search of cardio cure Genentech acquires potential cancer therapy from Protein Labs Chronic viral hepatitis: B is for billions Member States refuse to Lift Illegal Bans on GM Products DanioLabs Announces BBSRC Funding for Multiple Sclerosis Research Programme MorphoSys Antibodies by Design, ProQinase and Natural and Medical Sciences Institute (NMI) receive BMBF-promotion for Kinome-project Innate Pharma announces achievement of Discovery milestone in its research collaboration with Novo Nordisk Haptogen directors short-listed for Scotland Entrepreneur of the Year Award 2005 GENEREX BIOTECHNOLOGY BEGINS RESEARCH COLLABORATION ON NOVEL ALLERGY THERAPY WITH MAJOR EUROPEAN COMPANY Archemix Announces Milestone Achievement with Candidate Selection by Eyetech as Part of Broad Collaboration to Discover and Develop Therapeutic Aptamers for Ophthalmology TTP Labtech supply Sienabiotech Spa with compound storage capability Q Chip Appoints Jeremy Curnock Cook as Non-Executive Director. PIONEERING DRUG DELIVERY COMPANY ANNOUNCES EXTENSION OF MicroPlant RESEARCH COLLABORATION. Q Chip targets growing controlled release and cell therapy sectors with microcapsule delivery technology at BIO 2005 Launch of a Joint Venture Focused on Building Bioeconomies BI-201 against HIV-infection has today been given to the first patients Inpharmatica launches StARLITe(TM) and DrugStore(TM) MNLPHARMA announces data on Novel Antifungal Agent at BIO 2005 Symphogen A/S Appoints Paul Rohricht As Vice President Of Business Development Release of “Global Hubs and Nodes of Biotechnology: An International Scan of Biotechnology Strategies, Initiatives, and Institutional Capacity” IDBS launches E-WorkBook, a comprehensive electronic laboratory notebook. The keyboard is now mightier than the pen Prolysis And Essential Science Announce Extension Of Commercial Collaboration Oxford Biomedica To Chair Gene And RNAi Delivery Panel At The Bio 2005 Annual International Convention Ipsat Therapies Receives €3m From Finnish National Technology Agency Tekes Apollo Life Sciences Offer Over-Subscribed and Closes Early Borean Pharma raise 5.5 Million Euros in series A fundraising Oxford University researchers and local company work together to accelerate HIV vaccine research Fondation Autisme to create a bank of samples for research into the genetics of autism Syngene World’s First USB Memory Drive Gel Documentation Systemt Genomics specialist Geneservice announces management buyout from the Medical Research Council TTP LABTECH SUPPLY SIENABIOTECH SPA WITH COMPOUND STORAGE CAPABILITY AUREUS Pharma extends collaboration with sanofi-aventis Oxford Genome Sciences appoints Jeff Warren to the Board of Directors Syncroscopy Auto-Montage Pro generates high quality images for major new web site Genetix launches personal cell culture system Oxford Biomedica Signs Lentivector® Licensing Agreement With Pfizer BioInvent and Cambridge Antibody Technology sign Licensing Agreement Oxford Biomedica Presents Encouraging Innurex Preclinical Efficacy Data In Spinal Cord Injury Oxford Biomedica, Viragen And The Roslin Institute Report Achievement Of Avian Transgenic Milestone International Biotechnology Trust plc (IBT) Strengthened by High Profile Addition to the Investment Management Team COBRA SIGNS AGREEMENT WITH INTROGEN THERAPEUTICS FOR MANUFACTURING SERVICE DNAVISION STRENGTHENS ITS SERVICES IN PHARMACOGENOMICS by PROVIDING NEW MICRORNA ASSAYS BioPortfolio BioNews (News & Press Releases) May 2005Novagali Pharma launches Phase I clinical trial in oncology for its oral formulation of paclitaxel The German Resource Center for Genome Research (RZPD) to co-operate with Austrian Insilico GmbH Borean Pharma Granted United States Patent for Lead Therapeutic Candidate for Atherosclerosis Acolyte Biomedica Ltd Launches BacLite® Rapid MRSA Test - New high speed test promises to help prevent spread of MRSA Apollo Life Sciences to Raise $9.5 Million via ASX Listing Ablynx and the National Research Council Canada Sign Collaborative Deal to Develop NanobodiesT for CNS Disorders Research Borean Pharma appoints John Nieland as VP Preclinical Survey Identifies Best Way to Reach Scientists Using Catalogs Leading biomedical research center standardises genome sequencing operations on Genetix QPix2XT Sir Brian Richards joins the Board of Lipoxen Technologies Symphogen Appoints New Medical Advisory Board And Scientific Advisory Board Member Prolysis Raises $9.9 Million To Fund Preclinical Development IntegraGen Works With the Fondation Autisme to Create a DNA Sample Databank Oxagen Limited Raises $59.8 Million in Series B Private Venture Capital Financing Led by MPM Capital York Pharma plc Interim Results - Monday 23rd May 2005 Syncroscopy Auto-Montage Pro at the Natural History Museum - Rapidly Generates over 400 Accurate Images for Major Entomology Project Morphochem provides novel lead compounds for further development from successful collaboration Affitech AS in-licenses human oncology antibodies Meditech Clinical Data Published In International Cancer Journal Blue Membranes and Relisys Medical announce the closing of a worldwide licence and supply agreement for BlueM’s proprietary drug-delivery coating technology. Santaris Pharma initiates Phase I/II multi-centre clinical trial in Chronic Lymphocytic Leukaemia Bioinvent's Candidate Drug Against Hiv/Aids Approved To Enter Clinical Trials In UK An novel approach to the combination of AFM with optical spectroscopySyngene New GeneGnome Range Offers One Click Imaging of any Chemiluminescent Blot The SETsquared Partnership appoints Northbank Communications as PR consultants LifeCycle Pharma Successfully Completes €15 Million Financing Haptogen announce landmark collaboration with DaeWoong Pharmaceuticals to develop novel anti-infectives Oxford Biomedica Presents Updated And Encouraging Trovax Phase Ii Results In Colorectal Cancer At The 2005 Asco Annual Meeting Genetix launches QPDisplay - new automated phage display system Agilent Technologies to open new scientific training center in Shanghai Northbank Communications strengthens team with two promotions Northbank Communications wins financial communications appointments for York Pharma and CeNeS Pharmaceuticals Northbank Communications appoints Director of Finance and Operations Applied Biosystems/MDS Sciex is the Top Supplier in the Mass Spectrometer Market Dowpharma and Cytogen Agree to Develop PSMA Antibody for Treatment of Cancer Peakdale collaborates with Dynamic Extractions on new purification technology NiKem Research Srl and Hybrigenics SA Significantly Expand their Research Service Agreement in the Oncology Area IDBS acquires DAT-LABTM and leads the way to the next generation ELN York Pharma plc will be announcing its Interim Results for the six months ended 31 March 2005 on Monday May 23rd 2005. Atugen Achieves Milestones on Schering Target Validation Agreement OXFORD BIOMEDICA receives European patent for TroVax® covering 5T4 tumour antigen-targeted immunotherapy IDS Ltd acquire Suomen Bioanalyytiikka Oy (SBA) A NEW High Sensitivity, Multi-species Corticosterone EIA from IMMUNODIAGNOSTIC SYSTEMS LIMITED (IDS) 1,25-Dihydroxy Vitamin D EIA now available from IMMUNODIAGNOSTIC SYSTEMS LIMITED (IDS) Northbank Communications boosts marketing communications team with the appointment of Sarah Jeffery as Account Director Oxford Biomedica Presents Encouraging Preclinical Efficacy Data With Retinostat® In Age-Related Macular Degeneration Synco Biopartners And Cobra Biomanufacturing Form Alliance To Manufacture Plasmid Dna For Phase III Trials And Commercial Supply BSI Proteomics Introduces New Service-Structure Activity Relationships (SAR) by Nuclear Magnetic Resonance MEDITECH TO PRESENT AT GLOBAL HEALTHCARE CONFERENCE, PARIS TTP LabTech’s “hit-picker” can sample any well - PICK THE HITS WITH MOSQUITO® X1 Biomoda, Inc., an Invitro Diagnostics Company, Enters Into Agreement with Cytomyx, LLC a leader in translational medicine Western invasion threatens Japanese pharma's survival Novel combinations breathe life into COPD market Positive Phase I Data for Neurotech’s NT- 501 Encapsulated Cell Delivery of Ciliary Neurotrophic Factor to Eyes of Patients with Retinitis Pigmentosa ProImmune launches the new ProVETM MHC Pentamer Libraries BioPortfolio BioNews (News & Press Releases) April 2005BioCentral Investor’s Day Cements relationships between Investors and Midland’s leading biotech and medical companies The Science Advisory Board Reaches 25,000 Members TTP LabTech - FOUR INTO ONE DOES GO - comPANION 1-2-4 storage to processing at four times the speed Novagali Pharma names scientific advisory board IntegraGen to investigate the genetics of deafness as part of the €12.5M EuroHear consortium project New Economy Strategies And Goodfellow Agricola To Host National Roundtable On Regional Clusters Of Bioproducts Solexa Announces Agreement For $32.5 Million Private Equity Financing And Appoints G. Mason Morfit To Board Of Directors Immutep Enters Phase I/II Clinical Trials With Immufact(R), A Novel Immunostimulatory Factor Tigecycline would add to resistant infection armory GSK extends agreement with Peakdale for discovery research West Pharmaceutical Services Launches Novel FluroTec® Plungers for Prefilled Syringes in Europe TTP LabTech FOUR INTO ONE DOES GO - comPANION 1-2-4 – storage to processing at four times the speed MEDITECH SHOWCASES CANCER RESEARCH TO INTERNATIONAL AUDIENCE GENETIX New - fast, flexible and fully integrated system for array-CGH Cancer Vaccines: A Shot in the Dark? UK pharma in need of a check-up Thomson Launches its 2005 Liquent Regulatory Affairs Trends Survey Protagen AG installs new management and board of directors Genetix Competent Cells offer sub 60 second transformation Genetix Fully automatable Petri Dish is first of a new line Critical I - EuropaBio press release - Biotechnology in Europe poorly financed says study CeNeS and Tripos Announce Advances in COMT inhibitor discovery programme Dowpharma Relaunches Web Site, Will Make Donation to UNICEF Capsulution Nanoscience AG Wins Partner for the Construction of Industrial Production Facilities for the Manufacture of Nano-Capsules Mutabilis signs license agreement with Chiron Vaccines for vaccine development ESBATECH IS A WINNER OF THE 2005 RED HERRING 100 EUROPE BioInvest 2005 showcased new companies seeking investment CeNeS announces additional clinical data supporting the potential of M6G for the treatment of post-operative pain Solvo has been awarded the Hungarian Innovation Grand Prize Prescription Drug Patches Gaining Ground, Tackling New Therapies The FDA Role in Drug Safety Innovadyne Technologies granted key patent on core technology Marburg outbreak raises tropical disease profile CellCentric receives new funding and links up with the Babraham Institute USC Marshall School of Business Recognizes Contributions of Founders of Asia-Pacific International Molecular Biology Network IntegraGen appoints Gerald Wagner to the Board of Directors Ipsat Therapies Announces Positive Phase Ii Results For Lead Product Against Antibiotic Resistance And Hospital Acquired Infection IPSAT Therapies Oy Completes €7m Financing Round And Strengthens Board Of Directors Oxford Genome Sciences closes financing and moves to state-of-the-art proteomics facility USC Marshall School of Business Recognizes Prathap C. Reddy, M.D., as Winner of Asia-Pacific BioBusiness Leadership Award 2005 Alnylam Announces Manufacturing Agreement with Dowpharma(SM) for RNAi Therapeutics Solexa Names Linda Rubinstein Vice President And CFO BioPortfolio BioNews (News & Press Releases) March 2005Oxford Biomedica Receives Notice Of Allowance For Us Lentivector® Patent Peakdale and BioLeap collaborate on drug-like kinase library ESBATech starts drug discovery collaboration with Novartis tgAAVCF: Will The Latest Failure Be The Straw That Breaks Investor’s Backs? Big pharma set to move into HIV/hepatitis co-infection niche Agilent Technologies Presents Microfluidic Technology for Quality Enhancement of Mitochondrial DNA Sequencing NIH awards two-year grant to explore the causal relationship between epoetin dose and survival of hemodialysis patients receiving this therapy Haematologic Technologies, Inc. Has Been Awarded A Phase II SBIR Grant To Research And Manufacture Murine Coagulation Proteins And Related Immunoassays For Knock-Out, Transgenic, And Mouse Model Experiments Barroso Commission recognises contribution of biotech crops to European competitiveness Borean Pharma raises Euros 4 Million in series A fundraising Pre-Clinical data supports potential of Cobra's proprietary ORT-VAC oral bacterial vaccine Novagali appoints Dr Florence Barouki-Binlich vice-president development and medical affairs Global Life Science Ventures and Atlas Venture co-lead investment into Fibrex Medical Inc. Hana Biosciences Announces Positive Pharmacokinetic Study Results Of Ondansetron Lingual Spray PharmaVentures announces launch of ddcr.com New web site to enable drug delivery deal making Why Aren't Drugs Safer? - Is It Because We Need A Fundamental Understanding of the Receptor Response? IDS Ltd acquire Suomen Bioanalyytiikka Oy (SBA) Bayer Healthcare Diagnostics and Oxford Genome Sciences Partner in Proteomics-based Evaluation of New Biomarkers for Breast Cancer IntegraGen opens the door to its new Expert Center for genetic testing and counseling USC Marshall School of Business Announces Finalists for Asia-Pacific BioBusiness Leadership Award 2005 Syngene New 2-D Gel Scanner Guarantees Unbeatable Spot Detection Oxford Biomedica Demonstrates That Its Lentivector Technology Is The System Of Choice For RNAi Applications PETER LUNDBERG JOINS SOLEXA AS VP AND CHIEF TECHNICAL OFFICER Intercell is listed on the Vienna Stock Exchange Solexa Completes First Full Genome Sequence With Cluster-SBS Technology Archemix CEO to Present at 25th Annual SG Cowen Health Care Conference Nonlinear Dynamics’ TotalLab Software Suite now compatible with Mac SENEXIS ENTERS INTO A COLLABORATION WITH BIOFOCUS TO DEVELOP NOVEL “SMALL MOLECULE” DRUGS FOR THE TREATMENT OF ALZHEIMER’S DISEASE Study shows skin sterol identifies hidden CVD risks Biacore acquires FLEXChip System and Technology from HTS BioSystems Inc Member States fail to vote on biotech maize Sage Group Expands Team – Dr. Josef Bossart Joins As New Executive Director Agilent Technologies Introduces Whole Rat Genome Oligonucleotide Microarray Agilent Technologies Introduces Secure Web Portal for Designing Custom Microarrays for Genomic Research Update - Room for improved application of Orphan Medicines rules in Europe, says biotech industry - New White Paper sets out key recommendations LYNX AND SOLEXA LTD COMBINE TO BECOME SOLEXA, INC. BioAlliance Pharma Announces Results Demonstrating Styrylquinolines Targeting HIV Integrase Are Synergistic With Other Antiretroviral Agents DowpharmaSM Announces Agreement with Pfizer Inc using Pfēnex Expression TechnologyTM and Dow Solvent Extraction Technology Oxford BioMedica Announces Board Appointment Cytocell Technologies Completes Management Buy-Out. Management Team Takes Control of Biotech Diagnostic Screening Company Room for improved application of Orphan Medicines rules in Europe, says biotech industry - New White Paper sets out key recommendations GENOME express signs agreement with bioMérieux Sankyo and Daiichi plans show Japanese consolidation goes on Updated - Biopharmaceutical Contract Manufacturing: HighTech Business Decisions Report Indicates New Capacity and Improved Processes Keep the Industry on the Cutting Edge Updated - UNIBIOSCREEN’S Board Of Directors Appoints Pierre Hochuli As Chairman Of The Executive Committee NIH awards two-year grant to explore the causal relationship between epoetin dose and survival of hemodialysis patients receiving this therapy UNIBIOSCREEN’S Board Of Directors Appoints Pierre Hochuli As Chairman Of The Executive Committee Biopharmaceutical Contract Manufacturing: HighTech Business Decisions Report Indicates New Capacity and Improved Processes Keep the Industry on the Cutting Edge Grant Instruments acquires major share in Biosan SUPER-REPELLENT BIODEFENCE COATING FINDS HEALTHY APPLICATIONS Emerging oncology treatments: A focus on targeted therapeutics, supergeneric reformulations and supportive care Cresset Biomolecular Discovery Ltd Forms a Lead-Finding Collaboration with Pharmagene Medical Device Innovations closes £2.9m funding round Oxford Biomedica Announces Encouraging Results From Three Phase Ii Trials Of Trovax In Patients With Colorectal Cancer Cobra signs agreement with Hawaii Biotech Inc to manufacture two novel protein vaccines against Dengue fever and West Nile disease for US clinical trials Biopharmaceutical Contract Manufacturing: HighTech Business Decisions Report Indicates New Capacity and Improved Processes Keep the Industry on the Cutting Edge UNIBIOSCREEN’S Board Of Directors Appoints Pierre Hochuli As Chairman Of The Executive Committee MYORES, a EUR12 million European network of excellence focusing on muscle pathology research starts work BioPortfolio BioNews (News & Press Releases) February 2005Psoriasis: Biologics hope to reach 8mill undiagnosed sufferers Blockbuster brands generate generic goals Cobra signs long term deal with Neovacs SA to supply Phase I clinical trial material for a novel protein active immunization therapy-TNFa Kinoid Dr. Steven St. Peter Joins Atugen’s Supervisory Board SYMPHOGEN STRENGTHENS PATENT POSITION IN POLYCLONAL ANTIBODIES NextGen Sciences receives the Frost & Sullivan Technology Leadership Award for 2005 BioCentral Investors’ Day - Unique growth opportunities for venture capital investors ROLF STAHEL APPOINTED AS CHAIRMAN OF POWDERMED MNLpharma Strengthens Team Emerging treatments for inflammatory bowel disease Migraine treatment - a financial headache New trial of HIV/AIDS vaccine incorporates Cobra technology OXFORD BIOMEDICA AND VIRAGEN REPORT PROGRESS IN AVIAN TRANSGENICS BIOMANUFACTURING Sigma-Aldrich to Acquire Proligo Group to Strengthen Genomics Research Tools Portfolio Trends in drug patent expirations - new features from thinkPharm Top 7 Reasons To Attend IBC’s IBC’s Regulatory Submission Standards Conference Grant Instruments - for precision temperature control you can rely on Analytical Method Validation Case Studies of Practical Solutions for Various Assay Types and Stages of Drug Development InterMune's hepatitis strategy gets the right response Innovatives & supportive care way forward for Cancer drugs New ChemiGeniusXE 3 The Highest Resolution Multi-Purpose Image Analyser Available JPK Instruments AG - More space for NanobiotechnologySigma-Aldrich Offers Instant Savings with Its New Lab Start-Up Program BioImpact: Biotechnology for patients Industrialists call for a real industrial and financial policy for biotechnologies in Europe A Possible Mechanism for the "Broken Heart" Syndrome Q Chip - Microfluidics Venture Motors Ahead CATACHEM, INC. is pleased to announce the addition of Fructosamine (glycated proteins) to the DiscretePak™ and VetSpec™ line of diagnostic chemistry reagents. CATACHEM, INC. tiene el gusto de anunciar la adición de fructosamina (proteínas glucadas) a la línea de los reactivos químicos clínicos de diagnostico, DiscretePak™ y VetSpec™. Catachem is pleased to announce the availability of our VetSpec™ diagnostic test reagents for the COBAS MIRA™, discrete, random access analyzer. Catachem se siente muy contenta de anunciar la disponibilidad de sus reactivos de diagnóstico DiscretePak™ New Web Site for Microscopists Offers Simple Guide to Tools for Improving Digital Imaging Cobra extends its agreement with Oncolytics Biotech Inc. to provide long term manufacture of REOLYSIN® BIO Deutschland Calls on Amendment of the Stem-Cell Act Stem Cells: Yes to Research, but no Therapy? How Employers and Commercial Landlords Can Maintain a Mold-Safe Workplace ATUGEN AND ASINEX ANNOUNCE DISCOVERY PROGRAM FOR NOVEL PROTEIN KINASE TARGET CAMBRIDGE ANTIBODY TECHNOLOGY (CAT) GROUP PLC Progress in the treatment of peripheral arterial disease (PAD) Eisai's retinoic acid (RAR)-alpha receptor agonist as a candidate therapy for the treatment of lupus nephritis Asthma: alternative anti-inflammatory agents needed for patient subgroup Biacore launches new generation system for protein interaction analysis ExonHit Launches SpliceArray Service With GPCR And Ion Channel Microarrays Using Agilent Technologies' Microarray Platform Genetix launches breakthrough technology for the development of biopharmaceuticals OXFORD BIOMEDICA SIGNS LENTIVECTOR® LICENSING AGREEMENT New Agonist Antagonist Optimal Ratio Combinations as a Potentially Safer Class of Pharmaceutical Drugs The Overlooked Problem of Drug-Receptor Desensitization Screen Validates MNLpharma’s Compound Activity HIV vaccines: education key to partial efficacy success Migraine treatment financial headache for national healthcare systems Biomedical Photometrics Launches TISSUEscope SYMPHOGEN A/S NAMED BY TORNADO INSIDER AMONG EUROPE'S TOP 100 PRIVATE TECH COMPANIES CATACHEM, INC. announces the addition of Fructosamine (glycated proteins) to the DiscretePak™ and VetSpec™ line of diagnostic chemistry reagents Catachem announces availability of VetSpec™ diagnostic test products NEURO3d NAMED BY TORNADO INSIDER AMONG EUROPE’S TOP 100 PRIVATE TECH COMPANIES IntegraGen to take a leading role in unraveling the genetics of obesity in a €14.5M EU funded program Professor Cy Stein Joins Atugen’s Scientific Advisory Board Chronic hepatitis B and C: a chronic lack of effective treatment Strategic alliances – what’s the big deal? New Application of ChemiGenius2 To Analyse Large Proteins Associated with Type 2 Diabetes ESBATech hires CFO and Director of Preclinical Development New Ant Species Identified by Harvard University Using Syncroscopy’s Auto-Montage Software SyncroScan Improves Imaging of Human Hip Bones At Major European Bone Research Unit Incomplete control of HbA1c levels is the major drawback to current non-insulin antidiabetics Oxford Immunotec Appoints Stuart Rose as Global Marketing Director Genetix Limited launches QPExpression – new automated bacterial protein expression system Agilent Technologies Expands Custom Microarray Offering with Industry's First Shared-Design Program Malvern launches new web resource for protein researchers SCYNEXIS Europe appoints Geoffrey Sheppard as Head of Radiochemistry Scancell Signs New Agreement with Biovation to DeImmunise SC101 Details of £4.3 million Agreement Announced on 22 September 2004 Partner : Serono - Human Growth Hormone : Drug for Needle-free System 'Silent killer' osteoporosis quietly on the increase TiGenix completes recruitment of multinational Phase III clinical trial for cartilage repair Shantha Biotech Introduces Shanvac-B in BD Uniject™ SENEXIS APPOINTS CHRIS MOYSES AS CHAIRMAN AND DAVID SCOPES AS CHIEF SCIENTIFIC OFFICER Morphochem enters Research Alliance with Alcon to develop novel ophthalmic compounds Paradigm Therapeutics Ltd acquires Amedis Pharmaceuticals Ltd SOCS1 silencing dramatically increases the anti-cancer efficacy of dendritic cell vaccines Agilent Technologies Expands Microarray Platform to Address New Array-Based Genomics, Disease Research Applications Agilent Technologies Acquires Computational Biology Corp., Pioneer in Gene Regulation Analysis Agilent Technologies Announces Breakthrough for Cancer Researchers Studying Chromosomal Changes DOW PHARMACEUTICAL SCIENCES ACQUIRES BIOSKIN, EUROPE’S LEADING DERMATOLOGY CRO OXFORD BIOMEDICA SIGNS LENTIVECTOR® LICENSING AGREEMENT WITH BIOGEN IDEC Sorafenib offers hope in the battle for liver cancer survival IntegraChips™ to help develop “identity cards” for cancer tumours Peakdale Molecular appoints Glenn Killingworth to strengthen US Sales OXFORD BIOMEDICA PUBLISHES PRECLINICAL EFFICACY RESULTS WITH ITS PRODUCT CANDIDATE SMN1-G FOR SPINAL MUSCULAR ATROPHY $42.6 Million Five-Year Grant From Gates Foundation for Antimalarial Drug Brings Together Unique Collaboration of Biotech, Academia and Nonprofit Pharma BioPortfolio BioNews (News & Press Releases) January 2005BioPortfolio BioNewsCast Client Press Releases 2004 ArchiveBioPortfolio BioNews (News & Press Releases) December 2004Inpharmatica announces Chematica(TM) agreement with Novartis OXFORD BIOMEDICA LICENSES RETROVIRAL EX VIVO GENE DELIVERY TECHNOLOGY TO MOLMED SPA Exclusive Cooperation Between RZPD and NimbleGen Systems Enables Faster and More Flexible Microarray Analyses CRESSET BIOMOLECULAR DISCOVERY LAUNCH A NOVEL IN SILICO LEAD-FINDING TECHNOLOGY FOR MEDICINAL CHEMISTRY Serevent warning focuses attention on the need for combination therapy MorphoSys Generated Antibody Approved to Enter Clinical Trials Agilent Technologies, ALMA Honor Retired Lab Director with Distinguished Service Award for Analytical Lab Management CRESSET BIOMOLECULAR DISCOVERY LAUNCH A NOVEL IN SILICO LEAD-FINDING TECHNOLOGY FOR MEDICINAL CHEMISTRY Dr. Daniel Bucks, Director of the skin biology and drug delivery laboratory at Dow Pharmaceutical Sciences, speaks on skin permeation enhancement techniques at AAPS convention in Baltimore Vaxon CP_041206_Vaxon_ENG.pdfScreening Europe 2005 Agenda Complete Oxford Immunotec Appoints Dr Pamela Kirby as Chairman Dr Peter Wrighton-Smith of Oxford Immunotec Wins Entrepreneur of the Future Award Bionest Partners launches dedicated Start-up unit Arava: the 'sixth drug' that may soon be under fire 'Dementia Prevention' innovation to be trialed in US Genetically Modified Maize - Pollen Movement and Crop Co-existence New research proves that co-existence is NOT a problem Prolysis and Proteom Announce Drug Discovery Agreement BioPortfolio BioNews (News & Press Releases) November 2004Cobra increases quality capabilities and further strengthens compliance with the latest EC clinical trials directive Tigecycline offers new hope in the battle against MRSA Symphogen Presents Novel SymplexTM Antibody Isolation Technology for First Time at IBC Antibody Engineering Conference ASINEX AND BIOVITRUM ANNOUNCE 3 YEAR DRUG DISCOVERY COLLABORATION Cenomed, Inc. Secures License From Medical College Of Georgia To Intellectual Property And Technology For The Treatment Of Human Cognitive Disorders CAMBRIDGE ANTIBODY TECHNOLOGY (CAT)ANNOUNCES PRELIMINARY RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2004 ABLYNX APPOINTS EDWIN MOSES AS CHAIRMAN OF THE BOARD OF DIRECTORS Dow Pharmaceutical Sciences Appoints Sandra Calman, MD as Director of Clinical Research for the Solano Clinical Research Unit Promising Antegren data ruffles Serono Liver Cancer: Battle for survival Morphochem and Probiodrug collaborate in research and development PowderMed announces first clinical trial results - POSITIVE OUTCOME OF PHASE I DNA INFLUENZA STUDY Syngene - Major UK University uses ChemiGenius For Important Research on Blood Vessel Injury Syngene - A Major New Proteomics Software offering the World’s Fastest 2D Gel Analysis ADHD children not coming to attention of doctors Borean Pharma granted European Patent for Protein trimerisation Technology Yamanouchi to Spin Off Formulation Plant Roche Diagnostics Launches Highly-sensitive Polymerase Chain Reaction System Pfizer Japan to Bring New OTC Nasal Spray to Market NephroGenex Receives Seed Funding Sigma-Aldrich and Procognia Enter Exclusive Partnership for Commercialization of Functional Human Protein Arrays Eli Lilly Japan Receives Additional Approval for Vancomycin Hydrochloride for Injection Alfresa Holdings Begins Developing Molecular Marker Determination Reagent DeveloGen receives R&D Funds for diabetic Complications Project NIR DIAGNOSTICS RELEASES ADDITIONAL HemoNIRT DATA IntegraGen obtains European rights for MODY diabetes genetic testing and plans initial testing service for Germany next yea Sigma-Aldrich Introduces the First Antibody-Based Microarray Eisai Establishes Pharmaceuticals Marketing Subsidiary in India ProtoCOL at Major Vaccine Manufacturers Makes Testing Flu Vaccines Twenty Times Faster Double trouble hits Altana respiratory pipeline POWDERMED APPOINTS ADAM CHRISTIE AS CHIEF BUSINESS OFFICER Affimed Therapeutics and Biopharma Unit of Syngenta Enter Into Agreement to Co-develop Tandabs DOW AND UT AUSTIN EXTEND R&D COLLABORATION FOR DRUG SOLUBILIZATION BASED ON ADVANCED PARTICLE ENGINEERING BMD obtains FDA approval for its celiac disease diagnostic kit BioPortfolio BioNews (News & Press Releases) October 2004RNAi therapeutics company atugen receives Frost & Sullivan Award POTENT PRECLINICAL EFFECT OF NOVEL MELANOMA PEPTIDE VACCINE REPORTED AT THE SEVENTH INTERNATIONAL ANTICANCER CONFERENCE IN CORFU, GREECE Generex Biotechnology introduces Glucose Spray; First Product of the Diabetes Management System to reach the market Nonlinear Dynamics and GenoLogics Life Sciences Software announce partnership for integrated protein informatics solution SYMPHOGEN ANNOUNCES USD 25 MILLION FINANCING FROM INTERNATIONAL INVESTORS DR. DAVID OSBORNE, VP PRODUCT DEVELOPMENT AT DOW PHARMACEUTICAL SCIENCES, SPEAKS AT SOCIETY FOR INVESTIGATIVE DERMATOLOGY COURSE IN PHILADELPHIA Agilent Technologies Completes Acquisition of Silicon Genetics, Leading Provider of Life Science Informatics BIO Deutschland: Independent Biotechnology Industry Organisation Founded Tipranavir submission takes fight to HIV mutations Proteom and 14TM announce a strategic partnership in GPCR ligand design OXFORD BIOMEDICA AND ARIUS RESEARCH EXTEND COLLABORATION ON NOVEL CANCER TARGETS Sentrx Announces Reseller Agreement with Zenosis Limited Coincides with the Release of Zenosis Pharmacovigilance Modules MorphoSys Reports third quarter 2004 results. Company expects to obtain profitablity by 2005 Internationals Flock to see Best of Australian Biotech Ashlee Simpson - Too Young for Acid Reflux? - No - millions of children and teens have it Nonlinear Dynamics Appoints Elchrom Scientific as TotalLab Distributor First Annual RNAi Europe Conference and Exhibition - A Major Success DRI launches high sensitivity RNA purification products based on ChargeSwitch technology siFECTamineT is superior to in vitro market leader says new Biochemistry paper BioPortfolio Bulletin - CNS Disorders markets, news, links and reports Cardiovascular risks of HRT confirmed ADHD children not coming to attention of Drs Petra Biotek Announce the Availability of Technology Designed to Optimize Dose Modification, Accelerate Drug Development and to Limit Failure of Phase I and II Clinical Trials An introduction to the key CNS Disorders BioPartners Submits an Application for Approval of the First Biosimilar Recombinant Interferon alpha for Hepatitis C in Europe Visions of Biotechnology - a Community Forum into 2020 Best of Biotechnology on Show in Brisbane The CNS Market Outlook to 2009 The Cancer Market Outlook to 2009 The Cardiovascular Market Outlook to 2009 PARI Aerosol Research Institute’s Formulation Work and eFlow Featured in Corus Pharma’s Positive Phase II Trial Results Nonlinear Dynamics announce listings in Deloitte Fast 50 and Sunday Times Tech Track 100 ASINEX LTD. AND RECORDATI S.P.A. ANNOUNCE AN INTEGRATED DRUG DISCOVERY PROJECT ASINEX and SIENABIOTECH announce Lead Generation Collaboration COX-2 withdrawal - Therapeutic, R&D and pharmaceutical impact Flu season begins but a vaccine shortage awaits Nonlinear Dynamics announces another year of record figures Liponex announces U.S. patent and trial results for drug that boosts good cholesterol GM crop opponents’ theory on co-existence “exaggerated” New Automated Colony Counter Used to Detect a Range of Diverse Bacteria at Major Food Testing Centre Agilent Technologies' New Spin Cartridges Remove High-Abundance Proteins from Blood Serum Using Benchtop Centrifuge Human Genome Pioneer Joins AusBiotech 2004 - Unravelling the Genetic Code of Australia’s Biodiversity Umicore to manufacture product for Oxonica's photostable OPTISOLT UV Absorber TxCell raises EUR10.5 million Series A to finance phase I-IIA clinical trials Sigma Partners with Ingex on Targeted Gene Disruption Technology Sirenade announces breakthrough in the development of Tau-Directed theraputics for Alzheimer's PowderMed initiates a phase I clinical trial for a therapeutic Herpes Simplex type 2 vaccine GENEREX BIOTECHNOLOGY PRESENTS INFORMATION AT THE EUROCONFERENCE VACCINES 3 MEETING OF THE PASTEUR INSTITUTE IN PARIS ON THE USE OF NOVEL PEPTIDE VACCINE FOR MELANOMA GENOME express launches Gextrack, for food identification through DNA analysis Cambridge Healthtech Institute - Licensing and Partner Congress Emma Palmer appointed as Associate Director, head of Financial PR/IR Life after Vioxx - $2.5 billion up for grabs? HIV infection - changes in epidemiology driving R&D development and increased market value Dr. Eric von Hofe appointed Generex VP for Product Development & Scientific Affairs Icoria, Inc. Expands Partnership with Agilent Technologies to Include $11.7 Million ATP Grant for Informatics Entomed appoints Dr. Yves Ribeill to its board of directors Agilent Technologies Donates Microarrays to Vanderbilt University for Courses in Genomic Technologies, Bioinformatics Therapeutic activity of Bayer's BAY 43-9006 in renal cell carcinoma Osteoarthritis treatment and markets post VIOXX - reports, news, opinions Validated blood tests provide new alternative to liver biopsy for assessing status of liver disease in hepatitis C patients Agilent Technologies Announces More Than One Million Bioanalyzer Chips Sold Generex Biotechnology Corporation Oral-lyn™, the Company’s proprietary oral insulin spray formulation, and its RapidMist™ Diabetes Sigma-Aldrich and Rubicon Genomics announce GenomePlexT Whole Genome Amplification Licensing Agreement Atlas Venture and Global Life Science Ventures invest in Nitec Pharma AG Asthma Control and Asthma Impact Surveys Launched by QualityMetric NextGen Sciences Ltd introduces a new suite of revolutionary tools for molecular biology and protein research Cobra Biomanufacturing appoints Cathy Smith to strengthen North America Sales New molecular target identified for the prevention of Alzheimer's disease BioPortfolio BioNews (News & Press Releases) September 2004Improving levodopa-based complications to advance Parkinson's Disease therapies Solexa and Lynx merge to create future sequencing powerhouse Solexa Announces Successful Closure of $14.4m financing Sirenade Pharmaceuticals appoints Lynn Butler as CEO and restructures management team The Last Bastion: U.S. Pharmaceutical Prices Under Pressure GENOME express offers 10,000 free sequences to mark 10 years in DNA sequence analysis business Increased HIV survival rates generate upcoming treatment challenges The Eighth European Biotechnology Crossroads lines up wide range of events to give buzz to bio-business Pharma License Exchange™ North America's most efficient partnering forum Oct. 27-28, 2004 Sankyo's angiotensin II receptor blocker (ARB) olmesartan medoxomil demonstrates antiinflammatory activity in hypertensive patients. SWITCH Biotech AG: Founding of a rescue company after insolvency Inpharmatica Announces Biopendium Online(TM) Subscription with Chugai Inpharmatica Announces Biopendium Online(TM) Subscription with Chugai UPDATED Novagali Pharma completes second financing round of 14.2 million euros UPDATED Kereos and Dow Sign Licensing Agreement for Novel Targeted Imaging Agents Management's impact on biotechnology firm valuation and stock price Novagali Pharma completes second financing round of 14.2 million euros Omnitrope deferral casts doubt over biogeneric development Harsh environment threatens antibacterial development LUDWIG INSTITUTE FOR CANCER RESEARCH AND POWDERMED INITIATE A PHASE I CLINICALTRIAL FOR A NOVEL THERAPEUTIC CANCER VACCINE OXFORD BIOMEDICA SIGNS LICENSE AGREEMENT WITH MASSACHUSETTS GENERAL HOSPITAL, BOSTON UNIVERSITY AND DANA-FARBER CANCER INSTITUTE Pill Proof - Medication Compliance Kit ... A Life Saver Agilent Technologies' Venture Unit Invests in Genospectra Inc.'s Series C Round of Funding Capsulution NanoScience AG Fast and Economical Production of Surface-modified Nano- and Microstructures GlaxoSmithKline's IkappaB kinase 2 (IKK-2) inhibitor, TCPA-1 as a potential next generation disease modifying antirheumatic drug (DMARD) for the treatment of rheumatoid arthritis Bayer Technology Services and Physiomics sign collaboration Valuing In-Licensed Therapeutics and Technologies - Biotech and Pharmaceutical Congress Grant Instruments - Do the shimmy shake with Grant / Boekel atugen and Aventis to collaborate in identifying siRNA compounds with the potential for therapeutic development Xantos Secures Additional Finance of €4 Million ($4.8 Million) Peakdale launches mid-year intermediates catalogue NEW DRUG CANDIDATE FOR SEVERE ASTHMA FROM CAMBRIDGE ANTIBODY TECHNOLOGY (CAT) STARTS CLINICAL TRIALS Trials & Tribulations: Advances in the Development of Histone Deacetylase (HDAC) Inhibitors for the Treatment of Cancer Patient compliance is a $30 billion complaint Success of 'Genomes to Systems' Conference highlights the Move to Systems Biology Agilent Technologies Awarded 2004 Lilly Global Supplier Award thinkPharm.com announces drugs facing patent expirations in September 2004 IntegraGen appoints a Vice President Business Development Archemix to Present at Thomas Weisel Partners' Healthcare Tailwinds 2004 Conference CAMBRIDGE ANTIBODY TECHNOLOGY (CAT) ANNOUNCES FINANCIAL RESULTS FOR THE NINE MONTHS ENDED 30 JUNE 2004 BIOPHARMA: New Third Edition of Biopharmaceutical Reference Published New study reveals that reversing albuminuria reduces cardiovascular events in patients with diabetic nephropathy BioPortfolio Bulletin - Auction of Biotechnology Facility with Research and Development, Vivarium and Plant Support Equipment DailyUpdates - Today's breaking journal articles & press releases selected for the drug development sector Isotechnika's search for a partner continues New research encourages changes in the treatment and prevention of deep vein thrombosis in cancer patients CXR Biosciences Ltd Launches Investigative Toxicology Service Using Agilent Microarray Technology for Transcriptional Profiling Agilent Technologies Introduces Industry-First Features in Pharmaceutical Method Validation Software CTM Biotech - Appointment of Malcolm Brattle as Non-Executive Director OXFORD BIOMEDICA ANNOUNCES POSITIVE INTERIM PHASE II RESULTS WITH TROVAX IN COLORECTAL CANCER Dompe researchers develop chemokine receptor CXCR1 antagonist for the prevention of acute transplant rejection, chronic ischemic conditions and inflammatory disorders Agilent Technologies Introduces Whole Mouse Genome Microarray Solexa Announces the Appointment of John West as New CEO Toxicity problems continue to slow the development of CDK inhibitors Targeted therapies the aim for breast cancer treatment BioPortfolio BioNews (News & Press Releases) August 2004Pharmacological activation of transforming growth factor-beta1 (TGF-beta1) may be of benefit as a stroke prevention stategy Effect of CytoregR on Biomarkers in B16-F10 Murine Melanoma Clinical data further demonstrates the efficacy of Pfizer's pregabalin (Lyrica) in the treatment of diabetic neuropathic pain BioPortfolio BioNews and BioWatch - comprehensive news and email alerts services for the life sciences Agilent Technologies Increases Investment in Rosetta Biosoftware's Life Science Informatics Agilent Technologies to Acquire Silicon Genetics, Leading Provider of Life Science Informatics PARI Granted Orphan Drug Designation for Inhaled Cyclosporine – Potential New Therapy for Lung Transplant Patients Bionest Partners appoints Advisory Board Low level carbon monoxide exposure as a therapeutic approach to improving transplant outcome Evolva raises € 12 million A-round from International Investors Institute for OneWorld Health to Compile Comprehensive State of Infectious Diarrhea Treatments and Potential Solutions Vernalis extends cancer research collaboration with Novartis Institutes for BioMedical Research Cobra authorised to manufacture broad range of biopharmaceuticals for European Clinical trials Nonlinear Dynamics and Matrix Science Integrate Leading Proteomics Software Products UPDATE - It's not just drug discovery that's an expensive business UPDATE - DNA Research Innovations publishes its new expanded range of CST products in a new catalogue UPDATE - Images of World’s Largest Rotifer Reference Collection Captured on CD in less than Three Months by Auto-Montage UPDATE Building Biotechnology - Starting, managing, and understanding biotechnology companies' is a comprehensive resource on commercializing biotechnology Clinical data supports the development of insulin as a future treatment for memory and mood disorders? New TB test brings tuberculosis care into 21st century New rhinitis therapy should help patients to breathe easy Building Biotechnology - Starting, managing, and understanding biotechnology companies' is a comprehensive resource on commercializing biotechnology Images of World’s Largest Rotifer Reference Collection Captured on CD in less than Three Months by Auto-Montage DNA Research Innovations publishes its new expanded range of CST products in a new catalogue It's not just drug discovery that's an expensive business Peakdale and Cyprotex collaborate on drug-like screening compounds Innate Pharma raises 15 million euros in intermediate financing round Big bucks battling super bugs? Dowpharma sharpens focus on new expression systems; closes site THE WERCS CONTINUES TO EXPAND Company Adds Two Industry Veterans to Business Development Team PRODUCERS OF DRUG DISCOVERY TECHNOLOGY® WORLD CONGRESS ANNOUNCE 2nd ANNUAL ASIA PACIFIC EVENT Capsulution NanoScience AG Positive Half-Year Results Following Significant Rise in Turnover Lord Sainsbury, UK Minister for Science and Innovation, Opens the New Sigma-Genosys Oligonucleotide Production Site, in Haverhill, UK IntegraGen appoints Steve Lombardi as non-executive director Syngene - University of Cambridge Installs Innovative Imaging System To Save Time with Important Research on Plant Growth GENOME express and Institut Pasteur sign partnership agreement Nonlinear Dynamics and LifeGels Ltd (Previously Gradipore Ltd) Enter Progressive Distribution Agreement UPDATE - Peakdale launches 2nd GPCR targeted library ahead of plan UPDATE - QualityMetric announces royalty-free access to DYNHA® for scholarly research UPDATE - PROLYSIS ANNOUNCES APPOINTMENT OF PROFESSOR ROGER FINCH TO SCIENTIFIC ADVISORY BOARD UPDATE - GM planting regime: report of the Environment, Food & Rural Affairs Committee ignores important evidence submitted to it BioPortfolio BioNews (News & Press Releases) July 2004DNA Research Innovations launches GeneCatcher AnalytiCon Discovery: Discovery and Development of New Classes of Anti-Cancer-Drugs Grant BTD - round, rapid, reliable heating HomelandDefenseStocks.com Reports on The Security Implications of AIDS GM planting regime: report of the Environment, Food & Rural Affairs Committee ignores important evidence submitted to it PROLYSIS ANNOUNCES APPOINTMENT OF PROFESSOR ROGER FINCH TO SCIENTIFIC ADVISORY BOARD QualityMetric announces royalty-free access to DYNHA® for scholarly research Peakdale launches 2nd GPCR targeted library ahead of plan Pharmaceutical companies set to make a significant profit from anti-obesity drugs Agilent Technologies Introduces Qualification Service for GCs' Heated Zones Roche's Fuzeon offers hope...to the 20% of patients that receive it Agilent Technologies Gains Exclusive Rights to Sell SSI's CyberLAB Enterprise Content Management System What’s new at BIOPHEX2004? BiophexConfBroch8pg_CB_lo .pdfLife Sciences Day of DVC Deutsche Venture Capital – Highlights and Trends in the Biotechnology-Sector in Germany New Automated System for Microscopes Offers High-speed Slide Scanning to Create Precise Image Maps AnalytiCon Discovery: Successful collaboration with Kyowa Hakko Vernalis plc and Endo Pharmaceuticals Holdings Inc. Announce North American Licence Agreement and Co-Promotion Option for Frova™ BioPortfolio Bulletin - Bioterrorism, Anthrax, Smaalpox, Vaccines, New Reports Scancell Company Profile OneWorld Health to Work with Sanaria Inc. on Novel Malaria Vaccine Approach Advances in the development of corticotropin-releasing-hormone (CRH) receptor agonists as candidate analgesics Agilent Technologies Introduces Proteomics Product to Remove High-Abundance Proteins from Mouse Blood Serum Prolysis Company Profile Prolysis Fact Sheet.pdfNo recovery in Pharmaceutical Fine Chemicals market until 2005 DVC Deutsche Venture Capital achieves a substantial return on the asset sale of portfolio company Probiodrug to Prosidion Ltd. Morphochem appoints Sijmen de Vries as CEO The emerging role of the IL-4/IL-3 cytokine receptor IL-4Ralpha in asthma Haptogen granted European patent for it’s DBDx™ display technology Strong potential for cross risk-factor single pill therapies PHARMACEUTICAL COMPANIES SET TO MAKE A SIGNIFICANT PROFIT Tissue Microarrays : Market Assessment and Opportunities RNAi the hottest technology in drug discovery Proteomics market shows rapid growth Eden Biopharma Group raises £5million in investment André Pernet joins Bionest Partners as associate member National Biomanufacturing Centre paves the way for European Biotech Success BioPortfolio Bulletin - Life Science directories, Protein Crystallography, Directory of Molecular Diversity Suppliers, Tissue Microarrays Avidis names new CEO and management committee members OXFORD BIOMEDICA LICENSES LENTIVECTOR TECHNOLOGY TO VIRAGEN FOR AVIAN TRANSGENICS BIOMANUFACTURING atugen and Eisai Sign First Contract Research Agreement Early adopters of ePrescribing serve as models in a growing market METABOLIC SYNDROME REACHES EPIDEMIC LEVEL BioPortfolio BioNews (News & Press Releases) June 2004Biotech Insight Alert 30th June 2004 Charles River Proteomics Adopt Nonlinear Dynamics’ Progenesis Discovery Informatics Co-existence of GM and non GM crops: key principles for best management practices Development of a new Generation of Diagnostic Nano-Sensors Agilent Technologies' New Prep LC Columns Offer Highest Loadability among Commercial Preparative Columns BioPortfolio: CD-ROM of Life Science Companies, Pharmaceutical Outlook to 2010 Proteomic Research Services invests in Progenesis Discovery to enhance protein analysis services Harald zur Hausen Appointed as new Member of RZPD's Scientific Advisory Board New Survey forecasts over 70% revenue growth in systematic antifungal market over the next decade Biotech back on track.. A resurgence of Investor interest at the Biotech & Finance Forum BIOPHEX2004 promotes value innovation in the biopharmaceutical industry Cobra Biomanufacturing signs agreement to manufacture Coley's Toxin JPK Instruments offers advanced product for combined AFM and fluorescenceNonlinear Dynamics Release New Version of Progenesis Vernalis and Biogen Idec to collaborate on research for Parkinson’s disease Agilent Technologies Introduces Lysine-Tagging Reagent Kit for Fast, Accurate Identification of Rare Proteins Biotech in Autoimmune/Inflammatory Disease 2004: Revolutionizing the Market GM and non GM arable crops co-existing in North America without problems: says new research paper BioPortfolio: CD-ROM of Life Science Companies, American Hospital Register Generex Biotechnology announces a Letter of Intent for a joint venture and licensing arrangement for Oral-lynT in India, China and Australia Generex Biotechnology Presents Potential Uses of RpaidmistR Technology in Transmucosal Vaccines at Merieux Conference in France Syngene - ChemiGenius2 Automates Protein Array Studies Oxford Biomedica Publication – Lentivector® Gene Delivery System Results In High Success Rate In Avian Transgenics Program The Pharmaceutical CRM Outlook: Optimizing returns from operational and analytical CRM NovAseptic Sampling Systems Eliminate the Risk of False Positives Lord Sainsbury ‘eyes up’ Haptogen and Invinity at BIO 2004 Improved Method for the Study of Protein Expression Heat and shake with the new microplate thermoshaker from Grant Instruments Biogenerics market presents new commercial opportunity JPK Instruments Grants Exclusive Marketing Rights for Great BritainBioPortfolio: Auction of Genomic Equipment, BioAnouncement licensing service New study shows common management practices can cost a typical biotech company $2 billion in market value New Easy To Use, Microscopy Software Generates Precise 3-D Images in Seconds Ganymed Announces License Of Wt1 Immunotherapy Rights By Corixa And Kirin Agilent Technologies Announces Life Science's First Tool for Standardized Measurement of RNA Quality How can pharmaceutical companies best tap into the travel health market? Hybrigenics S.A. Optimizes Mapping of Protein Interactions with Millipore's Montage[R] PCR and SEQ kits FOTODYNE signs distribution agreement with bioinformatics developer Nonlinear Dynamics Oxford Biomedica Acquires Chiron Patents And Issues Shares To Chiron Prolysis And Essential Science Announce Commercial Collaboration Peter Buckel Appointed CEO of atugen AG New External Camera Range for ProtoCOL Allows the Analysis of Bioassay Plates and Microscope Samples Genomatix Adds Cell-Based Knockins To Its Vector Application Services Biotech Insight Alert 16th May 2004 Oxford Biomedica’s Innurex® Product Restores Limb Function In A Preclinical Model Of Avulsion Injury Pharmaceutical Portfolio Management: Integrated decision-making BioPortfolio BioNews (News & Press Releases) May 2004Archemix Presents at Friedman, Billings, Ramsey Investor Conference British biotechnology company Ardana Ltd. attracts DVC Deutsche Venture Capital as new investor Landmark new study identifies successful management practices in Biotech companies Takeda makes strategic investment in Lectus Therapeutics BioPortfolio: BIOPHEX 2004, ViroPharm Auction, BioNews, Aging Population eport Offers TekCel News: Introducing Adaptive Process TechnologyTNano-biotechnological Applications Excellently Positioned on the Asian MarketUK scientists pioneer novel treatment for motor neuron disease Genomatix Corporation, a genetic materials manufacturer, has relocated its operations to Roanoke and Blacksburg, Virginia Lilly's pemetrexed (Alimta) offers potential improvements in the treatment of non-small cell lung cancer (NSCLC) Maternal screening for hypothyroidism and hypothroxinemia KORN/FERRY INTERNATIONAL announces the appointment of Jacques Police Senior Client Partner, Global Life Sciences Group BioPortfolio: BPS Launches - Biomanufacturing & Biologics Clinical Trails Databases New Possibilities in Living Cell Microscopy JPK extends the NanoWizard® AFM System with BioCell(TM)Korn/Ferry International Announces The Appointment Of Jacques Police Institute for OneWorld Health Completes Patient Enrollment, Treatment In India for Largest Phase III Clinical Trial for Visceral Leishmaniasis (Kala Azar) Agilent Technologies Wins Decision on AP-MALDI Patent Agilent Technologies' New Protein Identification System Helps Biomedical Researchers Identify More Proteins with Greater Confidence Vernalis plc: Board changes Hybrigenics and Shanghai Institute of Materia Medica announce screening and discovery collaboration Inpharmatica signs PharmaCarta[TM] discovery collaboration with Procter & Gamble The BIOPHEX 2004 Conference, presented by Genetic Engineering News, helps put your products on the fast track to commercialization GM and non GM arable crops can co-exist in the EU without problems: says new research paper Syngene - New Application for ChemiGenius Offers Inexpensive Method of Analysing Proteomics Gels Pharma companies must implement initiatives to improve core drug discovery capabilities DEVELOGEN COMPLETES 19 MILLION EURO FINANCING ROUND PowderMed launched in spin out of powder injection DNA vaccine programmes from Chiron vaccines atugen and Sankyo Sign Multi-Year Contract Research Agreement New Microscopy Software from Synbiosis Accurately Counts Thousands of Cells in an Instant New Products to Improve Microscope Images On Stand G3 at MicroScience 2004 Northbank Communications Strengthens PR Team with the Appointment of Dr Douglas Pretsell as Account Manager NicOx's nitro-derivative of naproxen, HCT 3012, shown to be effective in a model of myocardial infarction BioPortfolio: Biotech Pharma Auction, Pain Special, Growthink Healthcare Venture Report RZPD's Affymetrix Service - Faster Detection of Genetic Variations in Humans atugen AG demonstrates in vivo proof-of-concept in siRNA therapeutics Results from the PACES trials provides further good news for Pfizer's Celebrex (celecoxib) Gabapentin as a first line treatment of spinal cord injury-related Morphochem AG Announces First Closing of its 15 Million Euros ($18.5 Million) Financing Round Oxagen Announces the Appointment of David U'Prichard as Non-Executive ChairmanRoche pipeline to fuel future growth Aptanomics and Nanosyn collaborate to discover new cancer drugsNew data reveals that the calcium channel blocker ethosuximide is an effective treatment of cancer pain R&D innovations to drive growth in osteoporosis market BioPortfolio: CNS resources, CANTAB Cognitive Assessment, Biotech Insight, DailyUpdates, Growthink Healthcare Venture Report Cancer treatment pioneer Scancell moves base to BioCity International patent granted to Capsulution NanoScience AG covering the manufacture of novel nano- and micro-capsules BioPortfolio BioNews (News & Press Releases) April 2004Dowpharma Announces Biologics Peptide Manufacture Scientists & Industry experts look to the future in the post-genome era Fluoroquinolone use set to increase, despite resistance warnings Pinnacle BIO Consulting launches BioOncology2004: Shifting Paradigms in Anticancer Therapeutics Merckle demonstrate superior safety of Licofelone the first dual COX/LOX Northbank Communications is Fastest Growing PR Consultancy in UK HU-320 identified as a novel synthetic cannabinoid with therapeutic activity in an experiment model of rheumatoid arthritis Dowpharma Signs Agreement for Drug Solubilization Feasibility Studies with Bristol-Myers Squibb Biotech Insight: Alert on ConjuChem, Type II Diabetes and GLP An increasing incidence of HIV/HBV co-infection calls for more effective treatment Drug delivery technology predicted to allow safer and more effective use of steroids in the treatment of rheumatoid arthritis Agilent Technologies and Partners HealthCare Announce Technology Supply Agreement for Mass General, Brigham and Women's Hospitals Agilent Technologies Donates Microarray Technology to Rhodes Norak Biosciences And SCYNEXIS Announce Chemistry Collaboration Eco-Safe Technical Services Ltd launches its Speci-Pak range of Diagnostic Specimen Packaging Inpharmatica announces agreement with Biotica Technology to provide comprehensive ADME support to their natural products programmes NicOx's nitrosulindac (NCX 1102) emerges as a candidate treatment of bladder cancer Gene silence to set to quieten neuropathic pain - Novartis research expands the potential of siRNA Novo Nordisk publish data demonstrating proof of concept for potassium channel openers as treatments of diabetes BioPortfolio: Biotech Insight, DailyUpdates, New Reports, Infectious Diseases resources New Microscopy Imaging Software European Preview on Syncroscopy Stand 351 at Analytica 2004 World’s Most Precise Colony Counter Presented by Synbiosis on Stand 452 at Analytica Eli Lilly's Duloxetine set to become the first widely used therapeutic treatment of stress urinary incontinence New data shows that intensive treatment of diabetes may lower coexistent hypertension and delay renal dialysis by up to 20 years Links between obesity/diabetes & Alzheimer disease Curacyte AG Presents Positive Phase II Clinical Trial Results For PHP In The Treatment Of Distributive Shock BioTech Stock Report: What Gives? RZPD GmbH and Protagen AG agree on license Eli Lilly’s Alimta to change the treatment dynamics in non-small cell lung cancer Type 2 diabetes as a risk factor for Alzheimer's disease - defective insulin-degrading enzyme as an etiological link? GANYMED names Rainer Wessel Ph.D. as President & CEO GREES publish new recommendations on the clinical development of disease modifying osteoarthritis drugs (DMOADs) BioPortfolio BioNews (News & Press Releases) March 2004Agilent Technologies Introduces Ion Trap Mass Spectrometer with 4x Improvement in Sensitivity Biotech Tracker: SGN-40 for Multiple Myeloma Vernalis plc: preliminary results for the eight months ended 31 December 2003 Vernalis regains control of North American rights to frovatriptan from Elan DailyUpdates - breaking journal and press release articles for the drug development sector Syncroscopy - New 3-D Imaging Software Makes Leading Technology Affordable for All Microscopists Merck & Co develop new leads for the treatment of bipolar disorder through the development of a new HTS assay of inositol monophosphatase inhibitors SWITCH Biotech AG Joint Forces Against Vitiligo ASINEX and SIENABIOTECH announce Lead Generation Collaboration Sulfonylureas vs thiazolidinediones for the prevention of diabetic nephropathy Cytomyx Licenses Cancer Database To Astrazeneca Frank Morich joins Innate Pharma's board of directors Biotech Tracker: Antibody Drugs from PDLI Advance Biotech Tracker: Gene Therapy Trial for Rheumatoid Arthritis Underway New data published on KW-7158, a novel treatment of overactive bladder Inpharmatica Announces Biopendium Online [TM] Subscription Agreement with Taisho of Japan Oxford Biomedica awarded £0.5 million from the UK department of health gene therapy research programme NMDA receptor antagonism limits visceral hypersensitivity and may offer an approach to functional gut disorders Shire Pharmaceuticals boosted by first Fosrenol approval MUNICH BIOTECH REPORTS ADDITIONAL POSITIVE DATA FROM MBT- 0206 PHASE I TRIAL NextGen Sciences announces distribution agreement with SCRUM Inc. in Japan Lynx and Solexa Jointly Acquire DNA Technology Assets Researchers report the efficacy of the bisphosphonate, YM529 in preclinical rheumatoid arthritis studies Agilent Technologies Upgrades Software for Mass Spectrometry-Based Proteomics Research Researchers report that controlling intracellular calcium levels may offer a new dual approach to hypertension and diabetes CHI's Portfolio Management, Project Management, Strategic Planning, Drug Discovery R&D and Knowledge Management Biotech Tracker: Orphan for Exelixis Biotech Tracker: Zenapax (Daclizumab) for Asthma Beta-O2 completes $2 million seed round led by Vitalife New research supports switching from to exemestane after two to three years of tamoxifen therapy in women with primary breast cancer Siegfried delivers solid results Syngene - New Imaging System has World Premier On Syngene Stand 461 at Analytica Inpharmatica announces ADME technology agreement with GlaxoSmithKline Capsulution NanoScience AG Diagnostic Particle Expert Appointed to Advisory Board New Medical Director at SOLVO Biotechnology Bionest Partners appoints senior consultant in corporate finance and strategic consulting Boehringer Ingelheim Researchers develop new therapeutics for the treatment of chronic hepatitis C infection DNA Research Innovation Ltd. Announces OEM Agreement with Isohelix Ltd Biotech Tracker: Riquent Still Has Hurdles to Overcome Biotech Tracker: E.U. to Review Inhaled Insulin Approval Application Cytokine targeting of dendritic cells to tumors produces dramatic anti-cancer activity Respiratory Syncytial Virus: Can antivirals make the grade? DVC Deutsche Venture Capital strengthens its management team in the technology field AMT Amsterdam Molecular Therapeutics (AMT) Obtains Orphan Drug Designation for its LPL Gene Therapy Product Potential of ghrelin receptor ligands in the treatment of cardiovascular disease New Contract Research Organization (CRO) Special Report Reveals 10 Ways To Make Better Hires Faster GANYMED Pharmaceuticals AG and the University of Rotterdam Establish new Cooperation Biotech Tracker: TKT’s I2S Trial Moving Forward Biotech Tracker: Risk of Adversities with Stem Cells Therapy in the Heart Granulocyte colony-stimulating factor (G-CSF) as a new therapeutic approach to myocardial infarction. Synbiosis: New Motorised Stage for Automated Zone Reader - Guarantees Rapid Analysis of Bioassay Plates Enhanced Epilepsy Therapy with Genetic Analysis COBRA SIGNS AGREEMENT TO MANUFACTURE AVIDEX' FIRST MONOCLONAL T CELL RECEPTORS Neuropathic Pain: Pfizer attempting to hold on to market leadership Yale researchers discover a role for Kv1.3 potassium channels in the etiology of diabetes as well as obesity Syngene - New Chemiluminescence Image Analyser Guarantees High Resolution for Greater Accuracy Biotech Tracker: Revlimid Orphaned Again NextGen Sciences attracts new investors and builds its Board of Directors OSI pharmaceuticals report on the pharmacokinetics, safety and efficacy of their anticancer thymidylate synthase inhibitor, OSI-7904L Comments on GM Foods: evaluating the Farm Scale Trials: report of the Environmental Audit Committee of 2 March 2004 PIPELINE 2004: PORTFOLIO STRATEGY CONGRESS FEATURES TOP 25 PHARMA, BIOTECHS, WALL STREET AND VENTURE CAPITAL THROUGH 4 TRACKS AND 80+ SPEAKERS Flinder Medical Centre researchers discover the cause of diabetic gastrointestinal dysfunction GM CROP TRIALS COULD POSE THREAT TO LAND VALUES abc welcomes Government approval of GM crops Overexpression of malonyl-coenzyme A (CoA) decarboxylase as a novel therapeutic approach to insulin resistance Agilent Technologies Announces 50,000th Shipment of Its Industry-Leading Liquid Chromatography System Cambridge Consultants - Encouraging Signs in UK Technology MarketsGlobal Life Science Ventures announces investment into CareX New data confirm that Fujisawa Pharmaceuticals' poly (ADP-ribose) polymerase-1 (PARP-1) inhibitor FR255595 limits neural damage in models of Parkinson's disease BioTech Stock Report: An Ounce of Prevention - Vaccines GREENPEACE AND MILK - THE FACTS on GM Animal FeedBiotech Tracker: Inhaled Cystic Fibrosis Therapy Data Encouraging Biotech Tracker: SGN-30 is an Orphan, but May Lose Out to Sister Construct Fungal infections: From specialty area to expanded population Adiponectin limits tumor angiogenesis-the missing link between obesity and increased risk of developing cancer? JPK Instruments Opens Door to Japanese Market Distribution Agreement Signed With the TOYO CorporationAgilent Technologies Combines Gene Expression, Proteomics and Reagents Businesses into New Life-Sciences Unit Agilent Technologies Introduces LC System for Proteomics that Combines Micro Collection and Spotting Capabilities BioPortfolio: BioOncology 2004, European Hospital Register, 2:1 Job Adverts Oxford Biomedica Plc: Preliminary Results For The Year Ended 31 December 2003 MetXia Clinical Trial UpdateJapanese researchers identify Interleukin-5 (IL-5) receptors as a target for preventing airway remodelling in asthma Biotech Tracker: Thalomid: What’s in a Label? Biotech Tracker: Neuroimmunophilin Ligands Still Need to Demonstrate Therapeutic Effect SCYNEXIS signs a drug discovery deal with Mitsubishi Pharma Oxxon Pharmaccines Appoints Frank Malinoski MD PhD as Chief Medical Officer Biotech Tracker: Phenoptin Trial Underway Biotech Tracker: Setback for Cortex’s Ampakine Program University of Texas Medical Branch researchers publish key data on respiratory syncytial virus infection Richard A. Lerner, M.D., President Of The Scripps Research Institute, To Lead Dyadic Scientific Advisory Board Montalier International Ltd., a leading international partnering consultancy and conference acquires Tri-Med Pharmaceuticals HRT declared unsuitable for first line osteoporosis prevention Inpharmatica selects MDL to distribute Biopendium worldwide Veteran Executive Richard Soltero To Head PharmaDirections BioPortfolio BioNews (News & Press Releases) Febuary 2004Global Life Science Ventures announces lead investment into NeurogesX APRICOT trial reveals promising therapeutic potential for the HIV/HCV co-morbid population Pharmaceutical Promotional Alliances: co-promotion v co-marketing Syngene - New InGenius12 System High Resolution Gel Documentation at a Low Price CHI's Business Strategies and Alliance Management Congress - Early Registration Biotech Tracker: Cystic Fibrosis Gene Therapy Results Not Impressive Biotech Tracker: CAT-192 Moves Forward Cyclacel to present at BIO CEO & Investor Conference Synbiosis: Automated Colony Counting Accelerates Development of Novel Pneumococcal Vaccines BioPortfolio: Pipeline Portfolio Congress, Asthma strategic intelligence resource. DXS And Sangtec Molecular Diagnostics Announce Licensing Agreement Of Scorpions[Tm] Technology BioTech Stock Report: Protein Design Labs Affymetrix Announces Completion of Smallpox Array Set Developed with CDC QualityMetric Clinical Trials Consulting Team: Health status varies. Our standards don’t Abingworth life sciences venture capital group appoints Michelle Doig How America built its high-tech economy. Technology Transfer in the Life-Sciences NextGen Sciences Ltd announced that it has been granted its third patent to protect the novel fluid dispensing system New from Grant - multi-function three-in-one 3D rotator The Consortium for Post Genome Science 2nd Conference New Report from PharmaPlus: HIV Pipelines & Deals Bionest Partners names new head of Medical Device Practice Cambridge Antibody Technology (CAT) Grants Licence To Wyeth Bionest Partners launches Medical Device Practice SENTRX Selected as Drug Safety Partner by Praecis Pharmaceuticals Incorporated BioPortfolio: Auction of Laboratory Equipment, Cancer strategic intelligence resource. Abingworth appoints Joe Anderson to manage quoted life science Pharma License Exchange™ partners with Needle & Rosenberg PC Inpharmatica announces ADME agreement with drug discovery company Cellzome atugen AG announces siRNA therapeutics program Progress in material sciences - Strength Through Shape Cambridge Antibody Technology (CAT) Group plc announces first quarter financial results 04-CAT-05_Q1_fin.pdfCambridge Antibody Technology (CAT) and Genzyme announce preliminary results from phase I/II trial of cat-192 for scleroderma Hepatitis C: Unmet need for treatment therapies leads to opportunities for Pharma companies Newly introduced Grant-bio PCV combined all-in-one centrifuge-vortex mixers Newly introduced Grant-bio PTR multi-function rotators from Grant Instruments Biotech Tracker: Accelerated Viramidine Development Oxford Biomedica Signs Lentivector Licensing Agreement With Merck & Co Boehringer Ingelheim enters into multi-target drug discovery collaboration with Morphochem Capsulution NanoScience AG: Innovative Technology Company Tripples Turnover DVC Deutsche Venture Capital further strengthens its position as leading European high tech investor Sigma-Aldrich Voted #1 in Service and Support by Survey of International Life Scientists Sigma-Aldrich Swiss Facilities Receive ISO 9001:2000 Re-Certification New Appointments to JPK Instruments AG's Supervisory BoardAgilent Technologies Provides Whole Human Genome Microarray with Industry-Leading Sensitivity and Scanner Compatibility PHARMA LICENSE EXCHANGE® pre-event information exchange, start date announced Unique Cell-based Bioassay Services developed by SBH Sciences Biotech Tracker: Immunomedics Antibody Moves Forward BioTech Stock Report: Close Call - Adolor CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC (CAT) 2004 ANNUAL GENERAL MEETING STATEMENT EXONHIT THERAPEUTICS announces EURO 8.3 MILLION in fund to support clinical development Japanese pharmaceutical companies: Survival through improved R&D ASINEX and Proteom Announce Successful BioScreening Project BioPortfolio BioNews (News & Press Releases) January 2004Integragen And Aventis In Collaboration Agreement for the Discovery of Genes Associated with Schizophrenia BioPortfolio launches life science email news alert and press release service CYCLACEL COMPLETES $39 MILLION PRIVATE PLACEMENT SBH Sciences: Unique Cell-based Bioassay Services (Updated). Biotech Tracker: Focus Limited to New Drugs at H&Q Avidex and ChemOvation Extend Collaboration on Rheumatoid Arthritis Small Molecule Affymetrix and Invitrogen Corporation Launch Reagents for GeneChip(R) Expression Array Platform STRATHMANN BIOTEC AG AND QIAGEN SIGN MANUFACTURING AGREEMENT WITH CORAUTUS GENETICS FOR VEGF-2 PLASMID PRODUCTION Biotech Tracker: Actimmune Fails in HCV Trial Syngene - GeneGenius Speeds up Quality Checking To Help Develop Effective and Inexpensive Anti-venom Biotech Tracker: Targeted Genetics To Begin Rheumatoid Arthritis Gene Therapy Trials Vernalis plc: interim results for the six months ended 31 October 2003 Northbank Strengthens PR team with New Account Manager Driving innovation - Tecan demonstrates new products at LabAutomation2004 in San Jose, California, USA Argenta Discovery Ltd Announces New Agreement with GlaxoSmithKline Aventis and Sanofi: Merger speculation continues Biotech Tracker: Lorus Antisense Moves Forward Biotech Tracker: Transkaryotic TKT Abandons U.S. Replagal Approval Urinary Incontinence: Growing market offers commercial opportunity Affymetrix Announces Launch of Zebrafish and Xenopus laevis Arrays for Whole-Genome Expression Analysis Curacyte announces successful completion of Phase II study for PHP in distributive shock BioTech Stock Report: Celgene Siegfried with strong fourth quarter CAMBRIDGE ANTIBODY TECHNOLOGY (CAT) and LONZA extend manufacturing agreement to supply clinical grade antibody drugs Syngene’s ChemiGenius2 at Harefield Helps Advance Research in Treating Heart Failure First Successful Certification Audit of a Biological Resource Center ASINEX Announces one year extension to Lead Optimization program with Avalon Pharmaceuticals Oxford BioMedica's TroVax receives approval to start Phase II trials in colorectal cancer US Patent Establishes Oxxon’s Leadership Position in Prime Boost Technology Biotech Tracker: Actimmune for IPF Biotech Tracker: Xigris for Children Biotech Tracker: Inhaled Insulins Continue To Be Unimpressive SCYNEXIS Announces Appointment Of Three New Members Biotech Tracker: Prialt Back on the Road Towards FDA Approval Biotech Tracker: Myriad and Abbott Expand Collaboration Biotech Tracker: Celltech Presses Forward With CDP870 Trials Biotech Tracker: ISIS 104838 Dosing Not Yet Optimal Dow enters NIH research agreement to develop rapid vaccine production system RZPD develops highly efficient products for genome research: siRNA resources for gene silencing AllCells LLC celebrating its 5th birthday with promotion on G-CSF Mobilized PBMC, PB CD34+ Affymetrix and Caliper Life Sciences Collaborate on Instrument Automation for Target Preparation Affymetrix Launches Plasmodium Anopheles genome GeneChipR Array for Malaria Study NADAG and SiREEN announce merger to form SIRENADE Pharmaceuticals and launch 20 million Euro financing round UK biotech company wins competition for space in Fairfax County BioAccelerator Affymetrix Launches Consortia Design Program to Create Whole-Genome Arrays for Plant and Animal Research Communities CAMBRIDGE ANTIBODY TECHNOLOGY (CAT) ANNOUNCES CLINICAL TRIALS UPDATE GENEREX REPORTS ON NOVEL MECHANISM FOR IMMUNOTHERAPY CURE OF PROSTRATE CANCER BioPortfolio BioNewsCast Client Press Releases 2003 ArchiveBioPortfolio BioNews (News & Press Releases) December 2003Biotech Tracker: Merimepodib Outlook Unchanged Biotech Tracker: Aeterna Keeps Swimming in Dangerous Waters Biotech Tracker: Reformulation of Prana Compound May Be Required Biotech Tracker: Riquent NDA Submitted to FDA Biotech Tracker: InterMune’s INSPIRE Trial Underway BioTech Stock Report today announced the release of its January 2004 issue. 2003 BioIndustry Review: Australia & New Zealand Advance flyer for 2003 BioIndustry Review.pdfGenomining's GetDB gives users immediate access to UniProt, the new protein knowledgebase launched this week Vernalis forms cancer research collaboration with Novartis Institutes for BioMedical Research, Inc. Biotech Tracker: HuMax-CD4 Fails for Psoriasis NICE guidelines highlight the importance of HepCgen's HCV genotyping service OXFORD BIOMEDICA ONCOLOGY UPDATE The 2nd Annual BioCapital Europe Expands To Include non-Benelux Companies Barcelona Hosts the 6th Summit of the Biotech & Finance Forum Biotech Tracker: LymphoRad at ASH Biotech Tracker: SGN-30 at ASH Biotech Tracker: Hope for HuMax-CD4 Acquisition of Clinomics Biosciences, Inc Placing to raise £1.915 million Neutral Fielding - a New Industry First Improves the Accuracy of Genius Image Analysers OXFORD BIOMEDICA PRESENTS PROOF-OF-PRINCIPLE DATA FOR ITS INNUREX(TM) NERVE REPAIR PROGRAMME CENIX Collaboration with Bayer HealthCare AG to Discover and Validate Novel Therapeutic Targets using Genomic High Throughput RNAi in Human CellsInnate Pharma and Novo Nordisk A/S sign licensing deal which opens new avenue in cancer immunotherapy THE WORLD ECONOMIC FORUM DESIGNATES PROCOGNIA LTD AS A TECHNOLOGY PIONEER FOR 2004 Catachem, Inc. Appoints Benjamin Twombly Vice President Sales and Marketing Catachem, Inc. Announces the Introduction of the Ammonia (NH) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit CliniGenetics announces promising pre-clinical results for novel approach in vascular disease therapy Novartis enters into research collaboration with Morphochem for use of its MOREsystem™ in lead discovery Catachem, Inc. Announces FDA Approval of the UIBC In-Vitro Diagnostic (IVD) Chemistry Reagent Kit Catachem, Inc. Announces FDA Approval of the Total Protein (TP) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit Catachem, Inc. Announces FDA Approval of the Total Iron (TFe) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit Catachem, Inc. Announces FDA Approval of the Creatine Kinase (CK) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit Catachem, Inc. Announces FDA Approval of the Creatinine (CREAT) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit Catachem, Inc. Announces FDA Approval of the Gamma-Glutamyl Transferase (GGT) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit Catachem, Inc. Announces FDA Approval of the Magnesium (MG) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit Catachem, Inc. Announces FDA Approval of the Chloride [340 nm] (CL) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit Catachem, Inc. Announces FDA Approval of the Triglycerides (TRIG) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit Catachem, Inc. Announces FDA Approval of the Lactate Dehydrogenase (LD) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit Catachem, Inc. Announces FDA Approval of the Glucose Hexokinase (GLU) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit Catachem, Inc. Announces FDA Approval of the Uric Acid (UA) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit Catachem, Inc. Announces FDA Approval of the Inorganic Phosphorus (IP) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit Catachem, Inc. Introduces the Plasma Free Hemoglobin (PFH) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit. Catachem Announces FDA Approval of the Alanine Aminotransferase (ALT) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit Catachem Announces FDA Approval of the Albumin (ALB) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit Catachem Announces FDA Approval of the Alkaline Phosphatase (ALP) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit Catachem Announces FDA Approval of the Amylase (AMY) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit Catachem Announces FDA Approval of the Aspartate Aminotransferase (AST) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit Catachem Announces FDA Approval of the Bicarbonate (HCO3) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit Catachem Announces FDA Approval of the Direct Bilirubin (DBILI) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit Catachem Announces FDA Approval of the Total Bilirubin (TBILI) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit Catachem Announces FDA Approval of the Blood Urea Nitrogen (BUN) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit Catachem Announces FDA Approval of the Calcium Arsenazo (CA3) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit Catachem Announces FDA Approval of the Cholesterol (CH) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit Affymetrix Launches Single Array for Mouse Genome Expression Analysis Catachem Introduces the Vitamin B6 (VB6) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit Biotech Tracker: Profile of Biogen IDEC IDBS to Supply Chemical Intelligence for Agilent Technologies' Synapsia Informatics Workbench Catachem Introduces the a-L-Fucosidase (AFU) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit Agilent Technologies Introduces Dual Loop Autosampler for HPLC Catachem Introduces the Glycated Serum Protein, Fructosamine (FR) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit. Syngene New High Resolution Gel Documentation System The Best Choice For Fast, Accurate Results BioTech Stock Report: Telik Catachem Introduces the Glycated Hemoglobin (A1c) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit. BioPortfolio BioNews (News & Press Releases) November 2003Syncroscopy Major Insect Imaging Project at Harvard Chooses Auto-Montage to Create International Species Standards OXFORD BIOMEDICA SECURES FUNDING FROM THE FOUNDATION FIGHTING BLINDNESS FOR ITS RETINOSTAT(TM) PRODUCT FOR VISION-LOSS Catachem Introduces the Total Bile Acids (TBA) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit Biotech Tracker: MDX-060 Data at ASH Vernalis plc: Research and Development Update Vernalis plc: Integration Update Northbank Communications Account Manager Awarded MBA SBH Sciences: Unique Cell-based Bioassay Services. Catachem Announces the Introduction of the Lithium (Li) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit. Anti-hypertensives: Landmark study data to drive sales Generics: FDA initiative to speed up introduction of generic drugs faces opposition ALS: a disease without a treatment? BioTech Stock Report today announced the release of its December 2003 issue. Catachem Announces the Introduction of the Potassium (K) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit. Inpharmatica Biopendium[TM] subscription with Aventis GM Crops can and should Co-Exist in the UK: It’s time to give UK consumers and farmers the right to choose GLAXOSMITHKLINE ENGAGES BIOWISDOM IN SECOND AGREEMENT FOR ONTOLOGY Co-existence of GM and non GM crops in the UK can occur without problems, says new research paper Catachem Announces the Introduction of the Sodium (NA) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit. Catachem Announces the Introduction of the Pre-Albumin (TBPA) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit Biotech Tracker: Exanta Excitement Builds Biotech Tracker: Pralnacasan Trial Suspended FIRST PRION REDUCTION PRODUCT PRESENTED AT THE EUROPEAN PLASMA FRACTIONATION ASSOCIATION CONFERENCE SCYNEXIS and GeneCare Research Institute sign anti-inflammatory drug discovery deal Proteome Systems awarded prestigious Technology Innovation Award ImmunoBiology raises further finance for developing influenza vaccines Archemix and Regado Announce License Agreement for Antidote-Controlled Aptamers Agilent Technologies Returns to Profitability in Fourth Quarter 2003 Company Exceeds Fourth-Quarter Expectations Survey of out-licensing biotech companies reveals Bristol-Myers Squibb perceived to be the best company to deal with, Abbott perceived to be the worst Biotech Tracker: Exanta Continues to Move Forward SWITCH Biotech AG First Clinical Results in the Treatment of Psoriasis Chemical Computing Group announces Excellence Awards for ACS CAMBRIDGE ANTIBODY TECHNOLOGY GROUP plc (CAT) PRELIMINARY STATEMENT OF RESULTS Rubicon Genomics, Inc. today announced the launch of their GenomePlex™ whole genome amplification (WGA) point of use kit Icon Genetics and Novoplant announce broad license agreement Synbiosis - New Colony Counting Study Shows åCOLyte SuperCount Matches Manual Counting for Accuracy BioZak InfoBase Inc. Announces Partnership with BioPortfolio.com. OXFORD BIOMEDICA REPORTS PROMISING PRECLINICAL RESULTS WITH MONUDIN™ IN THE TREATMENT OF MOTOR NEURON DISEASE New DigiGenius5 Imaging System Offers Affordable and Accurate Gel Documentation Biotech Tracker: High Quality Studies Support Use of Arixtra and Approval of Exanta Biotech Tracker: LymphoStat-B On Track Biotech Tracker: Riquent and LJP 1082 Presentations at ACR Biotech Tracker: ACR Data Support Continued ISIS 104838 Development DR. DAVID OSBORNE PRESENTS PERFLUORINATED SURFACTANTS AS SKIN PENETRATION ENHANCERS AT AMERICAN CHEMICAL SOCIETY NATIONAL MEETING Biotech Tracker: LymphoStat-B On Track BioTech Stock Report today announced the release of its November 2003 issue Agilent Technologies Introduces Flexible Software Solutions for Preparative HPLC Life Sciences CEO & Investor Forum Slated for March 22 – 23, 2004 Paradigm Therapeutics Limited announces the incorporation of a new subsidiary in Singapore Biotech Tracker: Xyotax Limited to Lower Dose in Phase III Studies Biotech Tracker: Lexiva Approved Biotech Tracker: Merimepodib Will Not Replace Ribavirin Serzone: New safety concerns ensures continued focus on antidepressants CAMBRIDGE ANTIBODY TECHNOLOGY (CAT) ANNOUNCES MANAGEMENT APPOINTMENTS Spectrophotometers for all 3i says Healthcare CEOs optimistic - Investment in Healthcare Market to Take Off Again in 2004 New Application of GeneGenius Is Helping to Identify Druggable Targets to Repair Spinal Injuries BioPortfolio BioNews (News & Press Releases) October 2003Babraham Bioscience Technologies expands number of companies on the Babraham Research Campus Curacyte awarded a €1.2M grant to fund development of Factor Xa inhibitors Agilent Technologies' New RNA Isolation Kit Improves Genomic DNA Removal up to 1,000X without Using DNase Co-existence of GM and non GM crops: case study of maize grown in Spain – new research paper now available LeadDiscovery’s DailyUpdates service expands to provide a platform for drug development-related services Affymetrix and PreAnalytiX Collaborate to Improve Gene Expression Results from Whole Blood RNA Samples Affymetrix and Qiagen to Collaborate on siRNA Research Using GeneChip® Technology Inpharmatica announces Biopendium Online[TM] subscription agreement with UCB Pharma Nonlinear Dynamics to participate in “The Proteomics Road Show” in Australia Nano-Microscopy: Latest Findings during the 2nd JPK InstrumentsAbcam in Top 5 of the fastest growing companies in the East Affymetrix Technology Selected for Next Phase of Human Genome Project AFFYMETRIX REPORTS RECORD PRODUCT REVENUE AND PROFIT Oxford BioMedica receives approval from GTAC for MetXia(R) to enter clinical trials in pancreatic cancer BIOWISDOM AND LINGUAMATICS TO PROVIDE AN ONTOLOGY AND NLP-BASED TEXT MINING APPLICATION TO ASTRAZENECA. Daily Updates 20th Oct: drug discovery for metabolic disorders, CNS, cardiovascular, inflammation Genomic Solutions signs OEM distribution agreement with Nonlinear Dynamics Meridica licenses Xcelovair - its dry powder inhaler technology - to Pfizer SWITCH Biotech AG: Stefan Schulze new Chief Executive Officer Paradigm Genetics and Affymetrix sign services and biotech access™ agreements AFFYMETRIX AND BIOMÉRIEUX EXPAND COLLABORATION AGREEMENT Biotech Stock Report - Looking Ahead Biotech Tracker: Bristol-Myers Will Benefit from Corgentech Drug Brand New Image Analysers Demonstrate their Excellence at Biotechnica CORRECTED - New appointments prepare Morphochem for cancer product development Breaking Journal Publications for the Pharmaceutical/Biotech Sector - Oct 17 Breaking Journal Publications for the Pharmaceutical/Biotech Sector - Oct 16 New appointments prepare Morphochem for cancer product development Breaking Journal Publications for the Pharmaceutical/Biotech Sector - Oct 15 DANIOLABS SCREENING COMBINATION PRODUCTS FOR COMBINATORX IN INFLAMMATORY BOWEL DISEASE Specialist Medical Lab Chooses CSI GC Package Capsulution NanoScience AG: New diagnostic particles CTM Biotech - From lab bench to clinic: new company to boost biopharmaceutical development Breaking Journal Publications for the Pharmaceutical/Biotech Sector - Oct 14 The International Symposium on Laboratory Automation and Robotics Announces List of Keynote Speakers Breaking Journal Publications for the Pharmaceutical/Biotech Sector - Oct 13 Biotech Tracker: Glaxo Asthma Antibody Has Significant Hurdles Immunotherapeutic targeting of ovarian cancer, renal defects in diabetes, advances in angiogenesis therapeutics, treatment of asthma SWITCH Biotech Selects 4SC as Partner for the Discovery and Development of Active Compounds for the Treatment of Psoriasis WPA (now part of the Biochrom group of companies) has developed this delightful easy-to-use spectrophotometer designed with the molecular biologist in mind Ipsat Therapies Announces Positive Clinical Trial Results for the Prevention of Serious Infections Associated with Antibiotic Resistance PS Analytical offers speciation Arsenic, Mercury and Selenium Speciation with Atomic Fluorescence Spectroscopy workshop Inpharmatica appoints new chairman - Board changes reflect growing focus on drug discovery Affymetrix Releases Data for 120,000 Validated SNPs Into Public Domain - First Large-Scale Release of SNPs From Perlegen Database atugen AG Expands Business Development Role Managing Risk and Growth through Strategic Alliances and Partnerships BioPortfolio Ltd. and BioJobNetwork announce a new Career Services Affiliation GEIF Ventures Matches Angels with a £100,000 Investment in Quotient Diagnostics Ltd Nanosphere Announces Protein BioMarker Detection Capabilities ICENI Seedcord Fund LLP invests £200k in Biotech Stock Report - Buying on the Dips BioPortfolio Special Bulletin - Acumen Journal of Life Sciences Biotech Tracker: Two Gleevecs May Be Better Than One Biotech Tracker: Thalomid for Prostate Cancer Biotech Tracker: Amgen Will Shine at ACR New approach to epilepsy - magnetic fields guide surgery BioPortfolio Bulletin - New Career Center, New Membership Scheme, Comprehensive Bio and Pharma News. ASINEX announces successful Lead Optimization project with Asahi Kasei Agilent Technologies Ships Whole Human Genome on Single Microarray to Gene Expression Customers for Evaluation Agilent Technologies and Stanford's Reynolds Center Collaborate to Research the Basic Mechanisms of Heart Disease HYBRIDON PUBLISHES CLINICAL SAFETY DATA ON GEM®231, A 2ND GENERATION ANTISENSE OLIGONUCLEOTIDE HYBRIDON PUBLISHES PRECLINICAL DATA ON Mdm2 ANTISENSE Inpharmatica appoints Director of Chemistry and recruits chemistry team Major milestone in human genome story: Affymetrix launches the whole human genome on a single chip BiotechTracker: Neovastat Trial Fails to Meet Primary Endpoint BiotechTracker: Poor Results for Preos Plus Alendronate Combination Therapy SOLEXA APPOINTS DR SIMON BENNETT AS BUSINESS DEVELOPMENT DIRECTOR Spectre of parallel trade looms large for the global pharmaceutical industry BioPortfolio BioNews (News & Press Releases) September 2003TheraSci advances its Parkinson’s Disease programme BiotechTracker: Alizyme Drug May Be Better Tolerated Than Xenical Procognia and Xcellerex Sign High Speed Glycoanalysis Agreement BioSeeker launches new report "Global structure of breast cancer R&D"Affymetrix Launches GeneChip® AutoLoader for the GeneChip® Scanner 3000 System New 48-array GeneChip® AutoLoader gives researchers walk-away freedom BiotechTracker: ISIS 104838 Moves Towards Phase III BiotechTracker: Antisense Drug Shows Promise for Diabetes Treatment Johnson and Johnson first customer for Affymetrix new 96-well high-throughput GeneChip array platform BioSeeker launches new report "Novel Tumor Vaccine Approaches"BioSeeker launches new report "The Global Structure of Prostate Cancer R&D"The World Skin Diseases Market 2001-2008The Gastrointestinal Market 2003: New Blockbusters and Competitive DynamicsDOW PHARMACEUTICAL SCIENCES NAMES DAVID W. OSBORNE VICE PRESIDENT OF PRODUCT DEVELOPMENT CAMBRIDGE ANTIBODY TECHNOLOGY (CAT) AND GENZYME CORPORATION STRENGTHEN COLLABORATION CAMBRIDGE ANTIBODY TECHNOLOGY (CAT) AND DYAX CORP. FURTHER EXPAND LICENCING AGREEMENT UK Scientists Deliver on Breakthrough Treatment for Rheumatoid Arthritis Sufferers Bio-Rad Enhances Imaging and Gel Analysis Software With First Ever 21 CFR Part 11 Compliance Features INFORSENSE ANNOUNCE ORACLE EDITION OF LEADING OPEN DISCOVERY WORKFLOW SOFTWARE NeuroNova AB announces collaboration agreement with Lundbeck A/S NeuroNova AB completes new round of financing BioPortfolio Bulletin - BioProcessing e-learning, new reports, 15-day FREE trial to BioWatch... Food Allergies: Drug makers set to capitalize? CAMBRIDGE ANTIBODY TECHNOLOGY REPORTS EUROPEAN APPROVAL OF HUMIRA OXFORD BIOMEDICA PLC INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2003 Novel drug delivery systems breathe new life into therapeutic peptides BIOWISOM ANNOUNCES ONTOLOGY LICENSE AGREEMENT WITH GLAXOSMITHKLINE BiotechTracker: MDX-010 Begins Phase II Breast Cancer Trial BiotechTracker: Thalidomide Plus Temozolmide for Melanoma BiotechTracker: NicOx Aspirin Derivative Is Easier on the Stomach BiotechTracker: Liver Function Monitoring Requirement Reduces the Convenience of Exanta New research driving ghrelin forward as an antiobesity target Ghrelin: Pharmaceutical & Therapeutic Opportunities for the Treatment of Obesity OXFORD BIOMEDICA AND ENTREMED ENTER AGREEMENT ON RETINOSTAT(TM) PROGRAMME BiotechTracker: Curis Approaches the Starting Gate Austrian plant sciences saved from "wallflower" status GeneChip® CustomExpress™ 11-Micron Array Format Sets New Standard for Data Capacity: 61,000 Transcripts on a Single Array BioTech Stock Report - anticipation Tularik Paradigm Therapeutics Limited announces the appointment of Dr Barry Kenny as Commercial Director Inpharmatica secures ADME agreement with British Biotech BioTech Stock Report today announced the release of its September 2003 issue. CAMBRIDGE ANTIBODY TECHNOLOGY AND XERION PHARMACEUTICALS EXPAND ALLIANCE INTO ANTIBODY DRUG DEVELOPMENT MICROMET, ENZON AND CAMBRIDGE ANTIBODY TECHNOLOGY SIGN CROSS-LICENCE AGREEMENT IN THE FIELD OF SINGLE-CHAIN ANTIBODIES AND PHAGE DISPLAY CAMBRIDGE ANTIBODY TECHNOLOGY ANNOUNCES PRODUCT LICENCE AGREEMENT WITH MICROMET AG CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC ANNOUNCES FINANCIAL RESULTS FOR THE NINE MONTHS ENDED 30 JUNE 2003 Greenpeace and FOE report on GM corn in Spain Affymetrix shows new DNA analysis chips at BioTechnica BiotechTracker: RNA Interference Reagents Break the Silence from Tool Companies BiotechTracker: Stem Cell Therapy for Parkinson Disease BiotechTracker Profile of Onyx Serono extends collaboration with Inpharmatica BioPortfolio BioNews (News & Press Releases) July 2003CANCER RESEARCH UK SUPPORTS ADDITIONAL TROVAX PHASE II TRIAL IN COLORECTAL CANCER DanioLabs announce revenue generating deal with KS Biomedix Paradigm Therapeutics Limited move to prestigious new premises on the Cambridge Science Park New GeneFlash from Syngene High Quality Gel Documentation at a Low Price BioTech Stock Report - ICOS AMBION AND CENIX BIOSCIENCE ANNOUNCE AVAILABILITY OF PRE-DESIGNED siRNAS COVERING THE HUMAN, MOUSE AND RAT GENOMES Steve Tomlin joins Cambridge Healthcare & Biotech as a Principal Associate Resistance to HIV drugs a growing problem Biotech Tracker: Genta’s Long-Term Commitment to Nucleic Acid Therapeutics Biotech Tracker: Profile of The Medicines Company Biotech Tracker: Crestor Approved Biotech Tracker: New Results May Resurrect SGN-15 Program Biotech Tracker: Pivanex Data Reassuring Biotech Tracker: Conjugates May Outperform Naked Antibodies Biotech Tracker: Profile of Biogen Biotech Tracker: Chemokine Inhibition For Rheumatoid Arthritis Looks Promising Xerion Pharmaceuticals and Xoma sign licensing agreement New Deal for Biochrom in USA Sentrx Announces the Appointment of Joseph Albano as CEO Oxford Biomedica obtains further fundamental patent for lentiviral gene therapy technology Synbiosis - Oxoid GmbH Chooses ProtoCOL Agilent Technologies and Paradigm Genetics Launch Mouse Oligo Microarray to Aid in Drug Reaction Research Agilent Technologies' Breakthrough Proteomics Product Simultaneously Removes Multiple High-Abundance Proteins BioTech Stock Report - Summer Doldrums Aventis To Develop Antibodies With ImmunoGen CORDIA-EuropaBio 2003 Organisers announce keynote speakers and chairs for world-class conference programme Inpharmatica secures ADME service agreement with Ionix Pharmaceuticals Amphora Research Systems Provides Oxford Biomedica with Improved Research Effectiveness and Intellectual Property Coverage with PatentSafe Results Suggest Limited Utility for GW433908 EVERSHEDS’ ASSOCIATED FIRM ADVISES ON LEGAL ISSUES FOR CONJOINED TWINS SEPARATION Biotech Tracker - Promising Preclinical Studies of New Roche Compounds for Diabetes The case for early ADME-TOX Drug discovery seminar programme launched by CXR Biosciences Analyst Comment 'Benelux Divided Over Drug Testing' Novel cancer vaccine to be manufactured from live bacterium GENOVAC grants NOSAN license BioTech Stock Report today announced the release of its August 2003 issue. Roche Vitamins and UpFront Chromatography sign global licence agreement Biotech Tracker - Exanta May Elevate Liver Enzyme Levels Biotech Tracker - Data Continue to Support Arixtra Use ASINEX Announces One Year Extension to Collaboration with Johnson and Johnson Pharmaceutical Research & Development, a division of Janssen Pharmaceutica N.V (J&JPRD) Proteome Systems expands relationship with CSIRO to developnew data mining tools for proteomics Syngene Appoints PerkinElmer as Canadian Distributor Guarantees Premier Service for Image Analyser Customers BIOWISDOM APPOINTS CHIEF TECHNOLOGY OFFICER The Harten Group - Latest Success Puts Harten Group on Cloud Nine HepCgen genotyping service helps fight Hepatitis C, a ‘silent epidemic’ abc welcomes today’s publication of the UK Government’s Science Review - Science supports the case for GM crops Full Review of GM Science Published Today CAT announces management promotions Dow Pharmaceutical Sciences Names Bill Anderson CFO & Vice President of Finance & Administration Biotech Tracker - Tifacogin Program for Sepsis Unlikely to Move Forward Biotech Tracker - Nipent Shows Promise for the Treatment of Non-Hodgkin Lymphoma Biotech Tracker - Crestor Approval Recommended Sirus Pharmaceuticals and GlaxoSmithKline Extend Collaboration on Neuropathic Pain IONIX ANALGESIC COMPLETES PHASE I TRIALS: SERIES B FINANCING SECURED Synbiosis New Automated ProtoCOL Systems Guarantee Highly Accurate Colony Counting Syncroscopy Image Analysis Software Helps Question the Evidence for Earth’s Oldest Fossils Biotech Tracker - Progen’s Growth Factor Inhibitor Moves Forward in Multiple Myeloma Biotech Tracker - Publication Ahead of Advisory Committee Meeting Supports Crestor Use Biotech Tracker - Aryplase Enters Phase III Biotech Tracker - Lorus Antisense Construct to Enter Phase II AML Trials Biotech Tracker - Puricase Program Moves Forward Biotech Tracker - Photodynamic Cancer Treatment Appears Promising Second TroVax Phase I/II trial results presented at the 94th annual meeting of the American Association for Cancer Research BioTech Stock Report - Biotechs Cambridge Online successfully updates the Data Centre for the Wellcome Trust Sanger Institute. Ocimum Biosolutions Collaborates with Hospital for Joint Diseases (HJD), New York, for Analysis of Translational Genomic Data In Musculoskeletal Diseases German Nano-Biotechnology for the Asian MarketBexxar Approved MDX-010 Enhances Both Positive and Negative Immune Responses Fujitsu appointed as InforSense's Distributor of New Kensington Discovery Station Software for JapanSolexa appoints Clive G Brown as Head of Bioinformatics Idec and Biogen: a natural union? Biotech Tracker - MDX-010 Enhances Both Positive and Negative Immune Responses CURACYTE RECEIVES FDA CLEARANCE FOR CLINICAL TRIAL BioTech Stock Report - Millennium POSITIVE RESULTS FROM METXIA PHASE I/II BREAST CANCER TRIAL BioPortfolio BioNews (News & Press Releases) June 2003Biotech Tracker - Biogen and IDEC Underwhelm Biotech Tracker - Copaxone Benefits Patients Who Fail Avonex Biotech Tracker - Another TNF Inhibitor Shows Promise Biotech Tracker - Exanta Continues to Impress BioTech Stock Report today announced the release of its July 2003 issue Biotech Tracker - Expanded Arixtra Label Approved Tm BIOSCIENCE LAUNCHES DRUG METABOLISM GENETIC TEST Tm BIOSCIENCE CLOSES $5.1 MILLION PRIVATE PLACEMENT Haptogen New anti-infectives in final pre-clinical phase Haptogen sign deal to access new display technology Nonlinear Dynamics employs Western Regional Sales Manager University of Cambridge grants exclusive worldwide licence to Paradigm Therapeutics to exploit exciting new drug target for the treatment of chronic pain Syngene - New Dedicated System for Chemiluminescent Imaging Long-Term Data Still Lacking for Inhaled Insulin Formulations La Jolla Pharmaceutical Presses Forward with Riquent Xyotax Receives Fast Track Status Agilent Technologies and Dharmacon to Use Microarrays to Analyze Cellular Effects of RNAi Gene Silencing for Drug Discovery Research Interview with UK's Leading Gene Therapy Company for Comment on Genetics White Paper Agilent Technologies Introduces Microarray Data Extraction Software Compatible with Any 1" x 3" Glass Slide Microarray Oxford BioMedica presents manufacturing process for gene therapy, ProSavin during BIO 2003Synbiosis New Automated Colony Counters European Biotechnology Crossroads presents international conference programme Argenta Discovery announces results for the year ended 31Biotech Stock Report - They Just Don’t Want to Quit NORTHERN IRELAND DIAGNOSTICS COMPANY INVESTS £123M IN LEADING-EDGE BIOTECHNOLOGY CURACYTE SCIENTISTS DISCOVER NEW ANTI-TUMOR AGENTS atugen extends agreement with Schering AG, includes RNA interference technology Expanded Cerezyme Label Likely in Europe Study Supports Arixtra Label Expansion EuropaBio and Partners announce preview programme for BiotechTracker - Isis and Eli Lilly Unwind Affinitak Collaboration BiotechTracker - Cystic Fibrosis Gene Therapy Moves Forward Syngene USA Opens New Headquarters QualityMetric Clinical Trials Consulting Team: PerkinElmer and Nonlinear Dynamics sign new OEM distribution agreement for leading proteomics software solution ImmBio raises €1million to finance respiratory disease vaccine developmentBiotechTracker - ASCO Data Support Bexxar Approval BiotechTracker - 63-Week Analysis Demonstrates Rebif Advantages Over Avonex BiotechTracker - Profile of Tularik BiotechTracker - Point Therapeutics Steps Up to the Challenge of Pan-Stimulation of Blood Cells Biotech Stock Report - WOW! Chiracon GmbH joins exclusive circle of Startup-Partners Ocimum Biosolutions launches gene optimization software, OptGeneTM Synexus announces big increase in turnover and move into profitability Syncroscopy New Application of Microscopy Software Helps Determine Man’s Evolutionary Progress with Greater Certainty ChemOvation and Cancer Research Technology have entered into a collaborative agreement in the field of target validation drug discovery BiotechTracker - ReoPro for Stroke Schroder Ventures Life Sciences fund raises over US $400 million for Third International Life Sciences Fund BiotechTracker - Generex To Initiate Phase IIb Oral Insulin Trials Biotech Stock Report - The BioCycle Biotech Stock Report - outlook on multiple myeloma therapeutics GATC and GENOVAC co-operate in the Field of Antibody Production Urch launches comprehensive report on Manufacturing in the Global Pharmaceuticals Industry BSI TACKLES MEMBRANE PROTEIN BOTTLENECK Zetia: Potential to reshape the cholesterol drug landscape? Multiple Myeloma: Increasing the therapeutic options BioPortfolio BioNews (News & Press Releases) May 2003Diabetes: time for a new regime? Anticonvulsants: Pfizer's pregabalin to top success of Neurontin? Cervical Cancer: commercial opportunities likely to remain despite preventative potential Lung Cancer: Eli Lilly’s Affinitac to challenge the cytotoxics HIV: Justifying premium pricing Rheumatoid Arthritis: Abbott looking for a greater share Hormonal Cancers: Key drivers in a market of change Pharmaceutical giants over-invest in promotion BiotechTracker - BioMS’s Multiple Sclerosis Drug Moves Forward BiotechTracker - Rebif’s New Label is Another Blow to Biogen BiotechTracker - ISIS-2302 for Pouchitis BiotechTracker - Remodulin for Pulmonary Arterial Hypertension BiotechTracker - Data Support Crestor Approval The Wercs, Ltd. Launches Technical Data Sheet Management Software Proteome Systems and Iberica announce research collaboration on identifying biomarkers for the treatment of Osteoarthritis Rosetta Biosoftware and Agilent Technologies announce licensing agreement with the Netherlands Bioinformatics Centre for the Rosetta Resolver system Agilent Technologies introduces new microarray labeling kit for sample-limited experiments BiotechTracker - Ketek Data at ATS Justify U.S. Approval BiotechTracker - MedImmune and Genaera to Begin Clinical Development of an Anti-IL-9 Antibody BiotechTracker - Disappointing Data for CDP571 and CDP870 in Crohn Disease Trials BiotechTracker - Antegren Improves Quality of Life for Some Crohn Patients BiotechTracker - Crestor Review BiotechTracker - PDLI Shows Some Guts BiotechTracker - Actimmune Update BiotechTracker - Axokine May Benefit Some BiotechTracker - Revmid Able to Affect Anemia But Not Other Aspects of MDSg BiotechTracker - Actimmune Data at the American Thoracic Society Meeting New USA Headquarters for Syncroscopy Promises Superior Service and Support for Microscopists Syngene - Automated Image Analysis of Proteins and RNA - Helps in the Fight to Prevent Heart Disease Use of SF Patient-reported Outcomes in Clinical TrialsSynbiosis Novel Application of åCOLyte Colony Counter Improves Quality Control at AstraZeneca Kick-off meeting of the Human Brain Proteome ProjectBiotech Stock Report - Hello Genentech! Bionest Partners offers advisory and management services to biotech, specialty pharma and medical device companiesOXFORD BIOMEDICA’S TROVAX® RECEIVES CLEARANCE FROM THE UNITED STATES RECOMBINANT DNA ADVISORY COMMITTEE TO ENTER A CLINICAL TRIAL FOR RENAL CANCERAgilent Technologies Reports Second-Quarter 2003 Results BiotechTracker Profile of Telik Tariquidar Trial Halted Protein Design Labs Antibody Fails in Phase II Asthma Trials Antisoma appoints HCC De Facto to spearheadRosetta Biosoftware and Agilent Technologies Release Rosetta Luminator System Version 2.0Biotica appoints Dr Mike Hayes as Non-Executive ChairmanNorthbank Communications moves to larger London offices Biotech Tracker News - Profile of Genta Biotech Tracker News - Replagal Data Do Not Address Regulatory Shortcomings Oxford offers bursaries for bioinformatics SMEs British Biotech and MerLion Pharmaceuticals establish collaboration for discovery and development of anti-bacterial drugs BMD raises 9.3 million Euros - The European leader in autoimmune disease diagnostics XERION PHARMACEUTICALS appointed anil singhal, Ph.D., Small Setback -- Forest Laboratories BSI PROTEOMICS ANNOUNCES LAUNCH: THE ARD™ FIVEPACK DYNAMIC CRYSTALLIZATION SYSTEM BIOWISDOM APPOINTS CHIEF SCIENTIFIC OFFICER TO BOARD Biotech Tracker News - Aldurazyme Approved Biotech Tracker News - Longer-Term Benefits of Zometa PROMETIC AND ALDEVRON EXPAND COLLABORATION TO DEVELOP NEXT GENERATION DNA PURIFICATION TECHNOLOGY Akubio’s New Facilities on Cambridge Science Park Now Fully Commissioned Proteome Systems and IBM announce first installation of ProteomIQ in Japan Affymetrix Announces GeneChip® CustomSeq SARS Pathogen Detection and Resequencing Array OXFORD BIOMEDICA AND THE INSTITUTE OF OPHTHALMOLOGY PRESENT PRECLINICAL RESULTS FROM THE RETINOSTATTM PROGRAMME FOR VISION-LOSS Ionix Pharmaceuticals - GRANTED PATENTS ON ANALGESIC DRUG TARGET New Image Analyser Fabrazyme Approved Cypher Approved BiotechTracker Profile of Alexion Dr John Padfield Appointed to Board of Akubio as Chairman BioPortfolio BioNews (News & Press Releases) March 2003Hybrigenics acquires Semaia Merged companies will leverage proprietary tools to identify and validate oncology targets and develop drug candidates Nonlinear Dynamics expands presence in North America with new distributor in Canada FDA Deputy Commissioner Dr. Lester Crawford and Dr. Joseph Jasinski of IBM Life Sciences to give keynote presentations at 3rd Annual Biotech Industry Conference Synoptics Opens New US FacilityObesity Drugs Disappoint Early Results for MDX-CTLA4 are Promising Axokine for Type II Diabetics The Human Genome is Sequenced Remicade for Sciatica Revmid Receives Another Fast Track Designation Expert Comments on Antegren Potential LymphoStat-B Advances Capsulution NanoScience AG signs development co-operation with Dutch OctoPlus B.V. Where Science and Art Meet Images Generated by Auto-Montage Shown at Prestigious Art Exhibition BMD announces new ISO 9001 certification Affymetrix at ESHG meeting - preview of new product Synbiosis Names Don Whitley Dealer of the Year OXFORD BIOMEDICA - COMPANY UPDATE AT AGM Wong’s BioTech Stock Report - Bumps In the Road Genentech Wong’s BioTech Stock Report - outlook on allergic asthma (“asthma”) therapeutics BIOWISDOM APPOINTS INDUSTRY VETERAN AS DIRECTOR OF SALES AND BUSINESS DEVELOPMENT Analysis Highlights Risks of Natrecor in Certain Clinical Circumstances Meta-Analysis Demonstrates Angiomax Benefit for Patients with Renal Impairment Novastan Plus ReoPro or Integrilin Promising for PCI Patients Campath for Multiple Sclerosis Exanta for Stroke Prevention Synthetic Bone Graft To Be Tested In Revision Hip Surgery Axokine Results Are a Bit Slim Profile of Tanox Cambridge Healthcare & Biotech Ltd tonight announced the formation of a new consulting company Picking Up the Trial Inhaled Insulin for Smokers siRNA Drugs are Promising as Research Gains Traction Crestor To Enter the Competitive Statin Market in the U.K. Zavesca NDA Amendment Submitted Biotech Tracker News - BioMarin’s Aryplase Moves Toward Phase III Biotech Tracker News - Affinitak Down But Not Out Biotech Tracker News - Copaxone for Lou Gehrig Disease Biotech Tracker News - Learning from Betabloc Trials Biotech Stock Report - The April report provides an outlook on rheumatoid arthritis (RA) therapeutics. RA is considered an autoimmune disease ALTANA Pharma obtains first license to atugen’s proprietary lipids New Time Saving Feature for Gel Imaging Software Allows User to Rapidly Recreate their Settings at the Touch of a Button Morphochem and Xenogen collaborate to develop novel drug candidates against bacterial biofilms The Automation Partnership Introduces PicoTube™ for Sample Management at DDT Europe Capsulution NanoScience AG acquires patents of former Aventis Research & Technologies SWITCH Biotech appoints new Chief Development Officer for the future clinical development phases of trial substances BioWisdom completes £2.5 million (€3.6 million) development capital financing metaGen and RNAx Announce Target Validation Agreement AMBION AND CENIX BIOSCIENCE PARTNER TO OFFER FIRST COMMERCIALLY-AVAILABLE HUMAN GENOME-WIDE siRNA LIBRARY Bio-Rad's WorksBase™ 1.1 is the first fully integrated proteomic informatics software platformNew Criterion XT precast gels have up to a 12-month shelf life.Bio-Rad's new 24 cm ReadyStrip IPG strips feature bar coding for high-throughput efficiencyNorth America’s most effective biotech/phama partnering forum - April 3-4, 2003, San Francisco, CA, USA Cytomyx enters into Europe-wide distribution agreement with Clinomics Biosciences, Inc Neurotech strengthens its position in ophthalmology through collaboration with INSERM and the Quinze-Vingts Hospital, Paris Nonlinear Dynamics appoints new General Manager for Asia Pacific Rim region Cambridge Antibody Technology Reports The Development Of Abthrax tm By Human Genome Sciences, Inc Biotech Tracker News - Study Highlights the Barriers to the Use of Genetic Susceptibility Testing Biotech Tracker News - Small Study Supports DX-88 Development Biotech Tracker News - Levitra Approved in Europe BIO-RAD CONFOCAL AND MULTI-PHOTON FRET MICROSCOPY IN LIVING CELLS Biotech Tracker News - Phase III Pexelizumab Trial Enrolled Biotech Tracker News - Preos is Looking Good Biotech Tracker News - Zavesca Launched in the U.K. Biotech Tracker News - Crestor Launched in Holland Biotech Tracker News - FDA Committee Gives Green Light to Certain Gene Therapy Trials Biotech Tracker News - Lymphoma Risk for TNF Inhibitors Biotech Tracker News - Priority Review for Extended Arixtra Administration Biotech Tracker News - FDA Panel Recommends Further Study of TNF Inhibitor Safety Pfizer/Pharmacia: Moving the goalposts Diabetes: time for a new regime? Anticonvulsants: Pfizer's pregabalin to top success of Neurontin? Syngene Software Upgraded for Multi-plexing Allows Seamless Overlaying of Separate Gel Images Multiple Myeloma: Increasing the therapeutic options Lung Cancer: Eli Lilly’s Affinitac to challenge the cytotoxics Rheumatoid Arthritis: Abbott looking for a greater share Hormonal Cancers: Key drivers in a market of change Pharmaceutical giants over-invest in promotion Biotech Stock Report - Picking Up the Trail MORPHOCHEM AND GBF SET UP COOPERATION AGREEMENT Tubulysin: new compounds against cancer OXFORD BIOMEDICA PLC (LSE:OXB) PRELIMINARY RESULTS FOR THE YEAR ENDED 31 DECEMBER 2002 Innate Pharma strengthens management team BioBridge Associates and biomaterials in Scotland OXFORD BIOMEDICA OBTAINS APPROVAL FOR TROVAX® TO ENTER PHASE II TRIALS FOR COLORECTAL CANCER BioPortfolio BioNews (News & Press Releases) February 2003BioTech Stock Report today announced the release of its March 2003 issue. Biotech Tracker News - Key Angiomax Data Published in JAMA Biotech Tracker News - European Approval of Amevive Delayed XERION PHARMACEUTICALS ENTERS INTO OPTION AGREEMENT FOR CANCER TARGETS FROM TUFTS UNIVERSITY Bio-Rad Launches Global Multi-Photon Newsletter Customer resources and experiences to be shared around the world Abcam expands into larger premises New laboratory system at GENOME express brings speed, flexibility and improved cost performance to DNA sequencing Biotech Tracker News - Avonex Adversity BioTech Stock Report - Stocks are trading lower mainly because a collection of economic indicators combined with war fears are producing investor uncertainty Bio-Rad image competition attracts entries of outstanding quality and scientific interest Mediatum GmbH Turning Visions into Capital New report GM Crops in Europe planning for the end of the moratorium, now available France Biotech and the SCI call for urgent European measures to boost innovation Evolva and DakoCytomation enter Research Collaboration NextGen Sciences Ltd (Huntingdon, Cambridgeshire, United Kingdom) appoints Tim Sutton as Chief Financial Officer VonSeal Meets NEW 95kPa IATA Regulations for Diagnostic Specimen and Infectious Substance Air Transports Dow Pharmaceutical Sciences Announces Recent Hires Capsulution NanoScience AG Renowned Pharma Expert has joined Scientific Advisory Board CliniGenetics and the Catholic University of Louvain (K.U. Leuven) extend research partnership for vascular disease Proteome Systems One of IBM's First Blade Server Customers Southern California's Premier Biomed Investor Conference Will Showcase a Rich Array of Life-Saving Biomedical Technologies Small Setback -- Forest Laboratories SWITCH Biotech AG Exclusive Licence to Medication for the Treatment of Skin Diseases Jerini initiates phase II clinical trial for treatment of Angioedema with Icatibant - Positive Notification for European Orphan Product Designation atugen AG and metaGen Pharmaceuticals Sign Target Validation Agreement Ribopharma AG strengthens Scientific Advisory Board PROMETIC LIFE SCIENCES AND AMERICAN RED CROSS FORM STRATEGIC ALLIANCE TO DEVELOP AN IMPROVED PLASMA PROTEIN PURIFICATION PROCESS Proteome Systems Releases New Generation of Intelligent Electrophoresis Solutions ChemOvation announces the appointment of a new Business Development Manager Biotech Tracker News - Natrecor/Johnson & Johnson Biotech Tracker News - McClellan Outlines His Leadership Priorities Biotech Tracker News - Protein Design Labs Targets Eos BioTech Stock Report today announced the release of its February 2003 issue. Wong’s BioTech Stock Report - Chips Ahoy! Affymetrix profitable 4th quarter Chiracon Extends Management Board Cytomyx and Purely Proteins to develop informatics led protein-based tools for pharmaceutical development ChemOvation and LeadDiscovery have entered into a cooperative agreement in the field of new target selection and development. UK Universities choose 2D image analysis solutions from Nonlinear Dynamics BioPortfolio BioNews (News & Press Releases) January 2003Biotech Tracker News - Amevive Approved Biotech Tracker News - Bringing Microarrays to the Clinic Syncroscopy New Plug and Play Microscope Cameras Software Integration offers Outstanding Colour Imaging for Microscopists Danish LEO Pharma Obtains License from SWITCH Biotech SmartBead establish valuable supplier relationships for UltraPlex GENOVAC's Technology Tested and Approved by CuraGen Biotech Tracker News - Aldurazyme Approvable Biotech Tracker News - Ketek Approvable, but Launch Likely Delayed 3D Molecular Sciences shortlisted for Business Weekly East of England Business Awards OXFORD BIOMEDICA AND KIADIS AGREE COLLABORATIVE PROGRAMME ON WOUND HEALING Ribopharma AG raises EUR 2 million in private financing round Biotech Tracker News - Gene Therapy Hits the SCIDs Again Wong’s BioTech Stock Report - Earning Season Genentech, Amgen, Abbott Laboratories Biotech Tracker News - Cambridge and Oxford Unite Biotech Tracker News - Pharma Continues to Validate Platform Technologies RiboTargets joins Partnership for Structural Biology at the European Synchrotron Radiation Facility atugen AG Discovers Novel Cancer Target Ultrafine Appoint Dr Rick Dyer as Head of Chemical Operations New ProtoCOL System For Rapid Quality Assurance of Vital Vaccines Millennium Seed Bank Chooses GeneDirectory To Help Save Rare Plant Species Alpha Bioverfahrenstechnik received GMP manufacture license for Biologicals Wisconsin Potato Technology Ammunition for Polish Fighter Jet Deal Wong’s BioTech Stock Report - focus on the pipeline Fabrazyme, Replagal & Aldurazyme Biotech Tracker News - Aldurazyme Moves Forward PROCOGNIA LTD ACQUIRES SENSE PROTEOMIC AND CLOSES $4 MILLION FINANCING ChemOvation announces its accreditation to BS EN ISO 9001:2000 standard BioTech Sage Report announces a new name Wong’s BioTech Stock Report LeadDiscovery dossier - Pharmaceutical development opportunities surrounding osteoporosis LeadDiscovery dossier - 5-HT7: Pharmaceutical opportunities in the fields of CNS and cardiovascular disorders LeadDiscovery dossier -Inhibitors of angiogenesis as treatments of rheumatoid arthritis LeadDiscovery dossier - Targeting endogenous inhibitors of apoptosis: Therapeutic Opportunities LeadDiscovery dossier - Dual prevention of osteoporosis and atherosclerosis LeadDiscovery dossier - The retinoids: Therapeutic & pharmaceutical opportunities Biotech Tracker News - Replagal’s Final Blow Biotech Tracker News - Fabrazyme Closer to Orphan Exclusivity CAMBRIDGE ANTIBODY TECHNOLOGY ANNOUNCES NEW NON-EXECUTIVE DIRECTOR The Automation Partnership Announces David Phillips as New Commercial Director Deloitee & Touche/techMARK Mediscience Forum - 6 February 2003, Downing College, Cambridge.Syngene - New Image Analysis Web Site Access to Interesting Facts Has Never Been Easier Biotech Tracker News - Ketek Recommended by FDA Advisory Committee Biotech Tracker News - Mixed Actimmune Data Research at ACNP meeting shows IVR useful in drug trialsBiotech Tracker News - BioBypass Disappoints Biotech Tracker News - BiotechTracker Profile of Amgen Biotech Tracker News - Rituxan for Hodgkin Disease OXFORD BIOMEDICA PLC – RESEARCH & DEVELOPMENT AGREEMENT WITH INTERVET PHARMA Nanosphere Inc. Receives Additional $5 Million in Third Round of Financing Synbiosis New Food Microbiology Application for Colony Counting Software Saves Time by Automatically Accounting for Food Debris Syngene - New Image Analysis Software offers Rapid, High Throughput MADGE Gel Analysis BioPortfolio BioNews (News & Press Releases) December 02New Bio-Rad VersArray ChipWriter Pro systems set standards for uniformity, spot density and reproducibilityBio-Rad ChipWriter CompactBiotech Tracker News - Publication Confirms Impact of Antegren in Crohn Disease Biotech Tracker News - Too Many Cooks Spoil the Drug-Coated Stent Biotech Tracker News - Raptiva BLA Filed Biotech Tracker News - Publication Confirms Impact of Antegren on Brain Lesions in Multiple Sclerosis Patients Tm BIOSCIENCE ANNOUNCES FIRST SUPPLY AGREEMENT Biotech Tracker News - Pafase Fails Sepsis Trials Biotech Tracker News - ALLHAT Studies will Impact Use of Non-Thiazides More than Use of Statins Biotech Tracker News - Xolair BLA Re-Submitted Biotech Tracker News - Study Should Lead to Increased Use of Natrecor Biotech Tracker News - Committee Recommends European Approval of Forteo Biotech Tracker News - Interim Data Support ISIS-2503 Development Biotech Tracker News - ODAC Recommends Bexxar Approval CDC Solutions Sponsors Worldwide Survey into Global Regulatory Submissions Trends TM BIOSCIENCE AND METRIGENIX ANNOUNCE LAUNCH OF UNIVERSAL ARRAY Oxford Biomedica plc awarded $0.5 million grant for motor neuron disease programme Porvair Sciences High integrity life science sample storage media …Advanced Chemtech Europe has announced the launch of a new totally automated peptide synthesiser. New Bio-Rad Certified Agarose Powder Line is complete, pure and GQT. The 'Biotechnology Success Story' is just taking some time outParadigm Therapeutics Ltd and Medivir enter alliance to discover protease inhibitor drugs Delta Search Labs and Proteome Systems to explore the intersection of computational engineering and proteomics Cytomyx announces the appointment of Dr. Nicholas Pay INTEGRA Biosciences Flexible tool for aspiration of liquid samples France's Strategic Council for Innovation backs French government measures to support research and innovation France Biotech welcomes new French government measures to boost international investment in France Tm BIOSCIENCE GRANTS EMPLOYEE STOCK OPTIONS Capsulution NanoScience AG Patented Technology for Innovative Drug-Delivery BioTech Sage Report - Putting News in Perspective – Millennium and Isis Proteome Systems and Nestlé announce Research Collaboration on the Glycoproteomics of MilkTherasci and Xenome enter nervous system drug discovery collaboration Biotech Tracker News - Genasense at ASH Biotech Tracker News - Exanta and Arixtra Shine at ASH Paradigm Therapeutics Limited raises £12 million in second round funding Genevac New tools for parallel Drug Discovery ... Big pharma: tightening the marketers' purse strings Genevac Acidic chemicals … EZ does it … Autoscribe Ltd. has announced the availability of a new suite of configuration tools within the latest version 4.0 of its Matrix LIMS The sequencing of the mouse genome, a landmark special issue from Nature Biotech Tracker News - AstraZeneca’s (NYSE: AZN) Exanta (ximelagatran) is in phase III clinical trials for the management of venous thromboembolism (VTE) Tm BIOSCIENCE LAUNCHES COAGULATION GENETIC TESTS BioTech Sage Report - Millennium (NASDAQ: MLNM) new drug application (NDA) to the FDA to market its anti-cancer drug Velcade Stay ahead of the competition with Reuters Business Insight strategic pharmaceutical and biotechnology management reports PwC BioScience Index & Share League September - October 2002 Biotech Tracker News - Millennium’s (NASDAQ: MLNM) Velcade (bortezomib) is a promising developmental compound Neurotech reports in IOVS that encapsulated cell based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosaCytomyx and Exalpha Biologicals in GPCR product development collaboration Biotech Tracker News - Bexxar Will Get Its Second Chance with the FDA Biotech Tracker News - Eprex Safety Concerns Continue to Benefit Amgen Biotech Tracker News - ASH American Society of Hematology Review INTEGRA Biosciences On-line cell cultivation applications bibliography BMD launches FIDIS[TM], a unique high-throughput diagnostics system Tm BIOSCIENCE REPORTS THIRD QUARTER 2002 FINANCIAL RESULTS BioPortfolio BioNews (News & Press Releases) November 02Simon Kerr joins TheraSci Board Synoptics Receives Important Business Accolade A Highly Prized ‘Technology Fast 50’ AwardMERGER CREATES NEW FORCE IN SCIENCE-BASED COMMUNICATIONS Autoscribe The productivity tool for every laboratory French government will announce boost for innovation, SCI told Biotech Tracker News - Forteo Approved Biotech Tracker News - Another Replagal Setback LeadDiscovery revolutionizes scientific surveillance with the launch of DailyUpdates Interferon State of the Science and Strategic Opportunities Parkinson's Disease State of the Science and Strategic Opportunities ENACT PHARMA Appoint Evolution Beeson Gregory to Explore Options for Maximising Shareholder Value JPK Instruments AG Profitable with nanobiotechnology after only 6 monthsBiotech Tracker News - Suboptimal Study Suggests Rebif Advantage Over Avonex Biotech Tracker News - Zavesca Approved in Europe BioTech Sage Report - small-capped biotechs in Phase II/III clinical trials, chemotherapy-induced nausea and vomiting (CINV) Syngene - New Software and Image Analysis Range Aromatase Inhibitors in Breast Cancer State of the Science and Strategic Opportunities AS Insights launch new report Insulin State of the Science and Strategic Opportunities Biotech Tracker News - Aldurazyme Should be Approved 17.5 billion Euro for the European Research Area - New biotechnology magazine elucidates European structuresAdvanced Chemtech - Off-the-shelf peptide libraries Biotech Tracker News - Zavesca's Second Chance Type I Gaucher disease Cambridge Display Technology Tops Deloitte & Touche Eastern Technology Fast 50 List with 4,786% Turnover GrowthMORPHOCHEM SIGNS DEAL WITH ASTRAZENECA TO DEVELOP NOVEL ANTI-THROMBOTICSJPK Instruments AG Nanotechnology for the Life Science SectorCME TELEMETRIX ANNOUNCES THIRD QUARTER 2002 FINANCIAL RESULTSHemosol Receives Clearance from U.S. FDA to Initiate Study of HEMOLINK in Orthopedic Surgery Mediatum - Management Boutique at the Interface between Pharmaceutical and Biotech IndustryBiotech Tracker News - Study Supports BioBypass Development Biotech Tracker News - Onyx’s Raf Inhibitor Shows Promise Biotech Tracker News - Boston Scientific Presents Additional Coated Stent Data Biotech Tracker News - Treatment Regimen for Pexelizumab Starting to Take Shape Eli Lilly's Xigris: struggling to overcome its problems in the sepsis market Hepatocellular carcinoma: pointing the way for other niche cancers Biotech Tracker News - Xyotax Promising for Ovarian Cancer Morphochem’s lead programme orally available inhibitors of Factor xa identified in preclinical studies as potential novel antithromboticsBioTech Sage Report - ReCap on BioGen, Celgene, ICOS, Genzyme, Imclone Biotech Tracker News - FDA Committee Recommends Pegasys Copegus Combo GENOME express increases focus on integrated collaborative high throughput services and solutionsGenovac Products for Drug Development in JapanOxford Biomedica plc David Higgins appointed vice president for business development NextGen Sciences Ltd (Huntingdon, Cambridgeshire, United Kingdom) is granted a patent for producing Protein BioChips BioPortfolio Recruitment in the Biotechnology and Pharmaceutical Sectors Biotech Tracker News - Prodrugs and Improved Drug Delivery for Parkinson Disease Synbiosis New ProtoCOL System For Faster, More Accurate Colony Count and Inhibition Zone Measurement Tm BIOSCIENCE CLOSES FINANCING OF $4.66 MILLION CAD Biotech Tracker News - FDA Committee Will Review Pegasys - Copegus Combination Biotech Tracker News - Advantages of the Zevalin Therapeutic Regimen Genevac Automated solutions for solvent removal ESA Analytical Determination of metanephrines aids in pheochromocytoma diagnosis … AlphaRx Inc. Announces Letter of Intent with Select Therapeutics Inc. to Sub-license Cancer TherapeuticThe Harten Group - Specialist Interim Management Company Announces Major Expansion AS Insights launch new report Erythropoietin State of the Science and Strategic Opportunities Biotech Tracker News - Hyseq Variagenics Combined Company May Still Lack Critical Mass Capsulution NanoScience AG MIT Expert for high-profile Advisory Board Biotech Tracker News - No Label Expansion for Copaxone into PPMS Biotech Tracker News - Seattle Genetics’ Clinical Pipeline is Not Its Most Compelling Asset BioSeeker launches new report "Ion Channels as Therapeutic Targets for Multiple Diseases"BioSeeker launches new report "New Targets and Drug Discovery Platforms in Antifungal R&D"LeadDiscovery launch new pharmaceutical dossier "Glycogen synthase kinase 3 inhibitors: Proof of concept and therapeutic opportunities for the treatment of diabetes, Alzheimer's disease, stroke & bipolar disorder" Oxford Biomedica plc update on cancer clinical plans SmartBead Technology Cambridge firm tops again in international technology competitionQUEST LAUNCHES WORLD'S FIRST NON-ANIMAL-DERIVED INGREDIENT RANGE FOR BIOTECH MEDICINES PiR Group: Qualified Persons (QPs) Have Never Had it So Good: Four-Wheeled Benefits and Base Salary Better Than Ever Nonlinear Dynamics expands presence in Europe with new distributor in FranceFrost & Sullivan Gives Competitive Strategy Award for Life-Science Mass Spectrometry Market to Bruker Daltonics, and CEO of the Year Award in Drug Discovery Tools to Frank Laukien Synoptics Honoured with Major SMART Award To Help Fund Development of a New Biological Imaging SystemCompugen Announces Licensing of its Z4000 System for Proteomic Research to Organon and Procter & Gamble Catalyst BioMedica fund DanioLabs in the search for novel treatments for neurological and ophthalmic disorders. Syncroscopy New Version of Microscopy Software Rapidly Generates Complete Images of Large SamplesBiotech Tracker News - New Xigris Data Only a Beginning Biotech Tracker News - Bexxar Round II (iodine-131 tositumomab) Biotech Tracker News - AMG073 Moves Forward Bruker Daltonics Reports Strong Growth in Revenue and Operating Income for the Third Quarter 2002 Chiracon - Valuable starting materials and resources for the technical and pharmaceutical chemistry Tm BIOSCIENCE announces coagulation test validation with 100% concordance to DNA sequencing Cytomyx announces the acquisition of Cambridge BioScience Advanced Chemtech - Flexible and productive Automated Peptide Synthesiser Synbiosis Automated Colony Counter is UKAS Accredited For Accurate Enumeration of Potentially Hazardous Microbes in WaterAGBIOS is excited to announce the release of Edition 2 of our highly acclaimed CD-ROM publication, Essential Biosafety. Licensing opportunity: adrenoceptor antagonists for sexual dysfunction Launch of The spilker report ™ Unique publication focuses on shortening drug development time BioPortfolio BioNews (News & Press Releases) October 02Capsulution NanoScience AG Another Development Co-operation with a Global Player Biotech Tracker News - Reminyl Fails to Meet Primary Endpoint Biotech Tracker News - Modest Pralnacasan Results in Rheumatoid Arthritis 6th European Biotechnology Crossroads becomes second most important biotech event in Europe APTANOMICS COMPLETES FUNDING TO DEVELOP NEW DRUG DISCOVERY PLATFORMS BASED ON PEPTIDE APTAMERSHemosol to Receive $20 Million In Additional Funding Biotech Tracker News - Phase III EXPRESS clinical trial Biotech Tracker News - Interleukin Profiles RA Patients Biotech Tracker News - Upcoming FDA Endocrinologic and Metabolic Drugs Advisory Committee Advisory Panel Meetings Biotech Tracker News - Exelixis - Glaxo Deal May Signal the Return of Platform Technologies Biotech Tracker news - Maxim Continues to Gain Back Lost Ground Biotech Tracker news - Sitaxsentan May Stack Up Well Against Other Pulmonary Arterial Hypertension Treatments Biotech Tracker news - Slow Progress for ISIS-2302 Biotech Tracker news - Cordis Drug Coated Stent Will Be Approved Biotech Tracker news - Prodrug Protease Product Produces Profound Progress Chemical Computing Group Signs Asian Distribution Agreement Co-operation with AnalytiCon Discovery GmbH New Drug May Reverse Bone Loss Without Estrogen’s Side Effects, Science Study SaysARIUS Research Inc. and Oxford BioMedica plc: collaboration attracts first development partner in Protein Design Labs Inc. Bruker Daltonics To Webcast Q3 Conference Call On November 4, 2002 Redasoft, Worley Sign Distribution Agreement for Visual Cloning Software in Australia. Hemosol Announces Webcast of Third Quarter 2002 Financial Results GENOME express launches proprietary technology to speed up gene discoveryINTEGRA Biosciences New adapter enhances economy of mobile Bunsen burner use Autoscribe Matrix LIMS features at WilliamsF1 Conference Centre … SWITCH Biotech restructures its activities Cardinal Health to Formulate Revolutionary Cardiovascular DrugThe next Generation Antifungals: Triazoles vs PeptidesScience: New Insights Into Prion Diseases?New rules for biotech products enter into force in EuropeThe biogenerics threat looms large Therapeutic Proteins: Strategic Market Analysis and Forecasts to 2010 Redasoft, Timberlake Consultants Sign Distribution Agreement for Visual Cloning Software in the UK, Italy, Spain, Portugal, and Brazil. Urch launches comprehensive report on generic drugs in Europe WITA Proteomics Completes Epilepsy Drug Mechanism Study with elbion AG MORPHOCHEM AND FOX CHASE CANCER CENTER ENTER INTO COLLABORATION TO DEVELOP NOVEL TREATMENTS FOR CANCEREnact Pharma 'message from the CEO' XERION PHARMACEUTICALS AND ARIUS RESEARCH SIGN COLON CANCER COLLABORATIONGenostar announces the availability of its bioinformatics platformAdvanced ChemTech the new ACTEvap™ transforms an ordinary laboratory rotary evaporator Genevac Optimal drying of microplate samples … TheraSci and BioFocus enter Drug Discovery Collaboration Acaris announces development and licensing agreementNextGen Sciences Ltd receives UK Government SMART award to develop new proteomics technologies for protein discovery applications Aneda & IBM sign Territory AgreementAndersen Piquet Strengthens Team With Three New Appointments Entelos Appoints Jon S. Saxe Chairman of the Board Enact Pharma Receive Further Support by NOIT Bringing the Total Investment to £1.8 Million Tuberculosis: new drug opportunities in an old market The Global Healthcare Review contains news, analysis and opinions on the healthcare and pharmaceutical industry. The Cancer Review brings you the latest news, expert analysis and research in the cancer industry. The Cardiovascular Review brings you the latest news, analysis and research in the cardiovascular industry. The CNS Review brings you the latest news, analysis and research in the CNS industry. The IDI Review brings you the latest news, analysis and research covering immune disorders and inflammation. The Infectious Diseases Review brings you the latest news, expert analysis and research in the infectious diseases market. Datamonitor's eHealth Review contains news, analysis and opinions from the eHealth industry. The Licensing Review contains news, analysis and opinions on the healthcare licensing industry ESA Analytical Chromatographic detection to Zeptomole (10 -21) levels Xerion raises Euro 12.3 Million in a Third Round of Financing to Progress Pre-Clinical Development of Antibody PipelineAdvanced Chemtech - Experienced source for custom peptide synthesis SmartBead places the UltraPlex system with UK's largest, independent analytical laboratoryGenevac latest technology for Centrifugal evaporation SUCCESSFUL RESEARCH GIVES ENACT POTENTIAL NEW ORGANOMETALLIC ANTI-CANCER PRODUCTS Argenta Discovery appoints New Chief Financial OfficerDanish Biotech Evolva A/S raises $1.7mnHaptogen’s unique approach is set to create valuable new therapeutic compounds Hemosol to Present at BioContact and UBS Warburg Global Life Europe's Health and Life Sciences companies rally to compete globallyThe European Biotechnology Crossroads, October 15-16 at Lille Grand Palais, takes its place in the top three European biotechnology events Synoptics Receives Prestigious Business RecognitionSolexa Announces Progress in its Single Molecule Array Technology3D Molecular Sciences Presents its New Patented 3D EncodedCapsulution NanoScience AG Fully automatic production of nanocapsules filled with selected active substancesBioPortfolio BioNews (News & Press Releases) September 02Baxter Healthcare Apply The Automation Partnership’s Robotics Technology to Help Produce New Generation of Influenza Vaccine From Formula One to Drug Discovery, Stephen Guy Joins TAP for Fast Moving Technology Commitment to the custom development of human antibody-based therapeutics - CAT & Chughai dealAdvanced ChemTech Europe the LabMate combines market leading solid phase chemistry technology with advanced solution phase featuresChemTech Europe announce publication of comprehensive source of information on Combinatorial, Organic and Peptide Chemistry ..Possible new cancer therapy shrinks tumors in melanoma patients, Science authors reportNonlinear Dynamics and Amersham Biosciences announce further collaboration by signing exclusive software deal for ImageQuant TL™Stefan Platz New Account Manager at STMP GermanyGM crops benefit small farmers in Spain commercially grown Bt maize poses no problem to food and feed chainbtmaizeinspainfinalreport16september.pdfCancer the generic impact Launch of MedSelection the Cambridge based international recruitment specialist for the pharmaceutical, healthcare and medical industriesPharmQuest announces cooperative agreement with FDA to co-develop a Carcinogenicity and Toxicology Data Management SystemAutoscribe Flexible sample inventory tracking system Genome express appoints François Pons as new business development managerTop 5 Pharma Advocate Cell Culture System for Drug Discovery ePharma: targeting the online health conscious Tm BIOSCIENCE ANNOUNCES FINANCING OF APPROXIMATELY $4.7 MILLION CAD ($3.0 MILLION USD) INTEGRA Biosciences Precision liquid dispensing in comfort Nanosphere Inc. Awarded Two NIH Grants to Assess Genetic Risk Factors for Cancer and Hypercoagulation Disorders Global Strategic Alliance to Deliver Drug Safety ProgramsThe Automation Partnership's (TAP) recently launched automated cell culture system for drug discovery - SelecT Proteom establishes business partnership with SC BioSciences in JapanOXFORD BIOMEDICA PLC APPOINTS NICK L WOOLF SENIOR VICE PRESIDENT OF CORPORATE STRATEGY DNA First-Aid Kit Helps Prevent Breast CancerA Protein Reality Show: A Photoactivatable GFP for Selective Photolabeling of Proteins and CellsTm BIOSCIENCE TO DEVELOP GENETIC TEST FOR MELANOMA PREDISPOSITION The thousand dollar genome - Solexa, making it a realityRedasoft Launches First Cloning Vector Search Engine for Life Scientists Genevac Molecular Biology to benefit from new evaporation products Novartis: Eastern biogenerics to bring multiple rewards Industry action overdue on postnatal depression Angiotensin: a target for Alzheimer's disease & CNS disorders ALRX News - AlphaRX Announces Data and Comparative Results on ARX2002ESA Analytical Expanding the versatility of gradient HPLC ... Cytomyx launches new Reagent Development Partnership Program CENIX BIOSCIENCE, A PIONEER IN RNAi TECHNOLOGIES, RAISES Euros 5 MILLION IN INTERNATIONAL FINANCING ROUNDAnti-Infectives Report 2002RiboTargets to Collaborate on EU Project for Research and Technological DevelopmentBiotechnology: FDA rule changes could boost generics Datamonitor launches Licensing ReviewDatamonitor launches eHealth ReviewDatamonitor launches Infectious Diseases ReviewDatamonitor launches Immune Disorders and Inflammation ReviewDatamonitor launches CNS ReviewDatamonitor launches Cardiovascular ReviewDatamonitor launches Cancer ReviewDatamonitor launches Global Healthcare ReviewAstraZeneca: a nail in the coffin of EGFr inhibitor hopes Male and female sexual dysfunction: Blockbuster indication for multiple pharmaco MIGRAGEN APPOINTS DR. LUCIO A.A. VAN ROOIJEN AS PRESIDENT AND CHIEF EXECUTIVE OFFICER Redasoft, Abacus Software Sign Distribution Agreement for Visual Cloning Software in India. XENTION DISCOVERY LAUNCHED WITH ACQUISITION OF AUTOPATCHÒ BUSINESS FROM CeNeS AND £4 MILLION INVESTMENT LED BY MVMAKUBIO APPOINTS CEO TO DRIVE DEVELOPMENT OF ACOUSTIC DETECTION TECHNOLOGYBMD brings remote clinical testing to French hospitalNeurotech refocuses on ophthalmic technologiesCME TELEMETRIX ANNOUNCES SECOND QUARTER 2002 FINANCIAL RESULTSRedasoft, CODSI Sign Distribution Agreement for Visual Cloning Software in Columbia.Hemosol Announces Second Quarter 2002 Financial Results Wireworks - Bioreactor Automation Software Accelerates the Drug Discovery ProcessBioPortfolio BioNews (News & Press Releases) August 02BioPortfolio BioNews (News & Press Releases) July 02BioPortfolio BioNews (News & Press Releases) June 02BioPortfolio BioNewsCast Client Press Releases 2002 ArchiveBioPortfolio Client Press Releases Site MapGenta and ImClone: The Tortoise and the Hare Evotec OAI Commission The Automation Partnership’s BasePlate XR BRAIN and Degussa extend their strategic partnership to discover novel enzymes for biocatalysisfinal day of the American Society of Clinical Oncology meeting Lining Up New Targets Cellomics - New HCS Reader at the forefront of drug discovery … PG Economics launch strategic report on GM Rice 2002-2012 Platform Technology vs. Drug Discovery EuropaBio is delighted to partner BIOTECHNICA 2005 and encourages the biotech industry to visit this international trade fair in Hannover this year Xolair Approved in Australia Interim Raptiva (Xanelim) Data Molecular Devices Announces Acquisition of Universal Imaging CorporationFuture Pain Drugs - A Report for 2002ARCHEMIX COMPLETES $51.75M SERIES A ROUND FINANCINGGenaissance (NASDAQ: GNSC) revealed interim results from ongoing analyses of its STRENGTH I Results From The American College of Cardiology Meeting Long-Term Benefit For Alzheimer Disease Patients Treated With Exelon InFUSE Bone Graft Approved Using Antisense, Monoclonal, and Standard Chemotherapy All TogetherBTECH REGULATORY RADAR - Tracking the Movement of Key Products Through (4 Mar 02) MEDMONITOR - Pearls from Recent Medical Journals and Conferences (28/1/02)RiboTargets Opens Structural Biology Unit in YorkExpanding Marketed Drugs into Alzheimer Treatment Innate Pharma raises Euro 20 million for clinical trials Cambridge Biotechnology Consultancy Takes Lead Role at Australian Biotechnology ConferenceStudy Demonstrates the Value of Myriad's BRACAnalysis Test Aricept Efficacious for Vascular Dementia Work Begins on Major Extension to RiboTargets Corporate HeadquartersBTECH REGULATORY RADAR - Tracking the Movement of Key Products Through Clinical TrialsSummary of European LRIG Meeting Programme Hurdles to Vevesca Approval DNAPrint to Present RETINOME Launch and Other Advancements at Upcoming Conferences Paul Lucas Elected to Board of Directors at Tm Bioscience Recommendations Should Lead to Increased Aranesp and Neulasta sales in Europe The Automation Partnership Agrees Specifications With GlaxoSmithKline On uHTSGlivec (Gleevec) Use Likely to Increase in U.K. Hemosol to Begin Phase II Chemo-Anemia Study in U.S. CAMBRIDGE ANTIBODY TECHNOLOGY ANNOUNCES NEW CHIEF EXECUTIVE OFFICER MORE POSITIVE RITUXAN DATA (rituximab, known as MabThera in Europe)CAMBRIDGE ANTIBODY TECHNOLOGY EXTENDS OFFER FOR DRUG ROYALTY CORPORATION TO 27 MARCH 2002 PERKINELMER WINS CONNECTICUT QUALITY IMPROVEMENT AWARDBtech News - MEDMONITOR - Pearls from Recent Medical Journals and Conferencesatugen AG Discovers Novel Cancer Target BTECH INVESTOR REPORTS WEEKLY: IMPROVING TREATMENTS FOR BREAST CANCER, NON-HODGKIN LYMPHOMA, DIABETES, AND CONGESTIVE HEART FAILURE Emisphere's Oral Heparin Is Not Superior to Lovenox Hemosol Responds to U.S. Food & Drug AdministrationThe INTEGRA Biosciences Group has announced the FIREBOY plus™ a versatile mobile Bunsen burner Cytomyx enters into Europe-wide distribution agreement with Clinomics Biosciences, Inc Btech News - J&J Will Not Pursue Topamax for ObesityBIO-RAD LASER SCANNING MICROSCOPY BUSINESS BECOMES THE CELL SCIENCE DIVISIONThomson Launches its 2005 Liquent Regulatory Affairs Trends Survey Evista May Have Cardiovascular Benefits in Some Patients Royalty Pharma AG to seek SWX Swiss Exchange ListingCME TELEMETRIX ANNOUNCES FIRST QUARTER 2002 FINANCIAL RESULTSGenomics Derived Drug Enters Clinical Trials German research ministry awards VISCUM AG 2.55 million Euro for collaborative cancer projectBTECH REGULATORY RADAR - Tracking the Movement of Key Products Through Clinical Trials (2/4/02)Marketing approval for Biogen's (NASDAQ: BGEN) Amevive (alefacept) - treatment of moderate-to-severe chronic plaque psoriasis. CME TELEMETRIX ANNOUNCES FOURTH QUARTER AND YEAR-END 2001 FINANCIAL RESULTSSense Proteomic Announces First Commercial Array of Functional Ion Channel ProteinsMEDMONITOR - Pearls from Recent Medical Journals and Conferences (18 March 02) D.C. BEAT - The Week's Biotech Related News from Capitol HillCAMBRIDGE ANTIBODY TECHNOLOGY ANNOUNCES POSITIVE 12 MONTH PHASE II RESULTS FOR CAT-152Btech Investor Reports: Targeting Sepsis BTECH REGULATORY RADAR - Tracking the Movement of Key Products ThroughBreakthroughs in the treatment of stroke and spinal cord injury on the horizon? The Cleveland Clinic and igeneon to collaborate on new cancer vaccine research Telik's Tumor Cell Killing Approach Looks Promising GENAISSANCE BEGINS DRUG DEVELOPMENTTm BIOSCIENCE REPORTS FIRST QUARTER 2002 FINANCIAL RESULTS Producing Therapeutics In Transgenic Animals and Plants Optimised solutions for EC-HPLC applications … MOLECULAR DESIGN INTERNATIONAL AND LEADDISCOVERY ANNOUNCE STRATEGIC PARTNERSHIP Histone deacatylases continue to feature at the cutting edge of oncology WITA Proteomics – Pharmagene Alliance Completes Research Milestone in Drug Development Programme Positive But Not Exciting Results for HuMax-CD4 in Psoriasis HORMOS MEDICAL CORP. RAISES EUR 18.4 MILLIONBioPortfolio BioNews (News & Press Releases)SciBiOn launches version 3 of Life Science E-Commerce platform: 'eSales PackageSense Proteomic announces the first array of functional proteins for the cancer research market.Tm Bioscience Licenses Universal Array Technology to MetriGenixMoritex Europe has announced the introduction of the i scope a new addition to their acclaimed Charm View skin analysis product range Advancing the treatment of cardiovascular disease with ThromboGenics Micronic NV. Colour innovation enhances high integrity tube capping system …CAMBRIDGE ANTIBODY TECHNOLOGY ANNOUNCES KEY MANAGEMENT PROMOTIONS PERKINELMER LIFE SCIENCES INTRODUCES NEW DIABETES RESEARCH PROBESBTECH NEWS - ABGENIX EXPANDS DEVELOPMENT OF ABX-IL8 TO CANCER INDICATIONSBtech News - British Government Compromises on Paying for MS TreatmentHemosol Oxygen Therapeutic Research Shows Promise for the Prevention of Tissue Reperfusion InjuryALRX - AlphaRx Announces Commercialization of "Flexogan" Topical Analgesic Products, Utilizing Proprietary & Enhanced Proven Drug Delivery TechnologyGuidant Acquires Cook IBA: Functionally isolating T-cells Redasoft, CLASS Sign Distribution Agreement for Visual Cloning Software in The Netherlands, Belgium, Luxembourg, Germany, Switzerland and AustriaPERKINELMER INTRODUCES TWO NEW MICROARRAYS FOR APOPTOSIS AND NEUROBIOLOGY APPLICATIONSNUNC LowBot Microplate LidsAricept Lowers Alzheimer Health Care Costs The next step in liquid handling automation ... Memantine NDA ALRX News - AlphaRX ANNOUNCES RESULTS ON HIGHLY EFFECTIVE, NOVEL, TOPICAL NON-STEROIDAL ANTI-INFLAMMATORY FORMULATIONSNew beginnings for brain cancer treatment BIOWISDOM ANNOUNCE A PILOT PROJECT FOR GLAXOSMITHKLINE UTILISING DISCOVERY INSIGHTtmPERKINELMER LAUNCHES NEW HIGH THROUGHPUT SCREENING MULTI-TECHNOLOGY Automating front-end clinical laboratory procedures … Aranesp Label Expanded AlphaRx Positions Itself For Future Growth With Their Proprietary Drug Delivery TechnologyAutoscribe - Cutting edge Laboratory Information Management What Came First, The Chicken or The Monoclonal Antibody? ENACT PHARMA FILES PATENT ON THE USE OF NEW IMPROVED BREAST CANCER DRUG Southern California Biomedical Council's 28th Biomedical Industry Networking ForumDouble recognition for wound healing - International prizes for research projects supported by SWITCH Biotech Novartis launch largest diabetes prevention trial to dateBtech News - The National Academy of Sciences Supports Legal Ban on Human ReproductiveAvonex Loses Again BTECH REGULATORY RADAR - Tracking the Movement of Key Products Through Clinical Trials (11 March 2002) Atkins ABC Multiplex, above ground on Schedule PerkinElmer introduces new, easy, step-by-step kit to fingerprint protein S-nitrosylation sites CeNeS Announces New Scientific Advisory Board Enact Pharma Patent Status UpdateOntogen Announces Formation of Oncology Advisory GroupSWITCH Biotech publishes articles in scientific journalseResearchTechnology Joins Forces with IBM to Provide Hosted Solutions For Clinical ResearchSlow Release formulation allows pig growth hormone to be effective for 21 days BioTech Stock Report today announced the release of its October 2003 issue. Bridging the gap between Medicinal Chemistry & High Throughput Synthesis Practical Management of Drotrecogin Alfa (Activated) Therapy in Patients with Severe SepsisTracleer Efficacious in Children for treatment of pulmonary arterial hypertension (PAH) BTECH INVESTOR REPORT - Out of the ASHes: The Resurrection of AnticoagulantLatest advance enables Multiphase Time Course experiments with Laser Scanning Microscopes.MEDMONITOR - Pearls from Recent Medical Journals and Conferences (19/2/02)D.C. BEAT - The Week's Biotech Related News from Capitol HillThe SCBC 4th Annual Investment & Strategic Partnering Opportunities Conference Inhibition of angiogenesis as a new treatment modality Phico Therapeutics Ltd, a young company developing novel antibiotics, has recently closed its early stage financing roundBayer Chooses Empliant to Support Acquisition of Aventis CropSciences STEM CELLS GET A LITTLE HELP FROM THEIR FRIENDS Kirchhoff Consult AG (DE) - Royalty Pharma AG announces IPOOxford Biomedica plc and Arius Research Inc Sign collaborative programme in tumour immunotherapy No Evidence that Preos Increases Cancer Risk BTECH NEWS - Controversy Over Pharmacopeia / Eos MergerBtech Report: Biotechnology Industry Valuation Btech Investor Inc - ProfileSpectral's Sepsis Diagnostic Test Back On Track for U.S. BTECH NEWS - BIOTECH INTEREST HIGH AT THE JP MORGAN H&Q HEALTHCARE CONFERENCETracleer Efficacious in Children for treatment of pulmonary arterial hypertension (PAH) Crestor Approval Concerns Olympus Life and Material Science Europa announce the DP30BW digital microscope camera MEDMONITOR - Pearls from Recent Medical Journals and Conferences (11/2/02)Aventis and Genta Partner To Develop Genasense Cellomics have announced the launch of the KineticScan™ HCS Reader, a system optimised for studying the dynamics of living cells. Unique Cell-based Bioassay Services SBH Sciences Pharmacogenomics A personalized approach to medicineRad Bioscience Wins Israel’s Biotechnology Incubator CompetitionBumps in the Road for Angiozyme and Heptazyme Development UK biotechs: biting off more than they can chewMolecular Devices Expands into Europe with General Manager of European OperationsFDA approved IDEC's (NASDAQ: IDPH) Zevalin (ibritumomab tiuxetan)Btech Investor Inc - News archive 2Fast Track Regulatory Approval for TheraCIM h-R3, a new drug for the treatment of Epidermal Growth Factor Receptor (EGF-R) RiboTargets Listed by Tornado Insider as one of Europe’s Top 100 Start-UpsBTECH REGULATORY RADAR - Tracking the Movement of Key Products Through Clinical Trials (28/1/02)Another Disappointment for PDLI Miravant's Disappointment Will Preserve QLT's MarketD.C. BEAT - The Week's Biotech Related News from Capitol Hill (4 Mar 02) SWITCH Biotech expands third round of financingRibotargets - Appointment of new non-executive directorIDEC (NASDAQ: IDPH) has halted clinical trials of its therapeutic monoclonal antibody IDEC-131 CARDIOME REPORTS DOSING OF FIRST PATIENT IN PIVOTAL PHASE II STUDYBtech Weekly Report: Novel Aspects Of Diabetes Care Bayer Chooses Empliant to Support Acquisition of Aventis CropSciences Hemosol Announces First Quarter 2002 Financial Results Sanger Institute Plays Host to Successful Laboratory MeetingGleevec Resistance Tm Bioscience Attracts In-House Management Team to Advance DNA Diagnostic Marketing StrategyNorthview Biosciences Forms West Coast Incubator Perkinelmer presented Frost & Sullivan award for protein array product line strategyBTECH REGULATORY RADAR - Tracking the Movement of Key Products Through Clinical TrialsRemodulin Approvable For Pulmonary HypertensionSECOND WEEKLY BTECH INVESTOR REPORT AVAILABLE FOR FREE DOWNLOAD BTECH WEEKLY REPORT: EXPANDING INDICATIONS FOR REMICADE AND ENBREL BioPortfolio BioNews (News & Press Releases) Jan to May 02Betabloc Fails Due To Adverse EffectsInactivation of highly infectious materials Btech News -TRACLEER WILL NOT EXPAND INTO TREATMENT OF CONGESTIVE HEART FAILUREGet Hands–On Expertise at MicroScience 2002NEW FLUOROPHORE WALL CHART NOW AVAILABLEAbgenix Cancels Development of Its anti-IL8 Monoclonal Antibody Kirchhoff Consult AG (DE) - Royalty Pharma AG announces IPOThe American Society of Clinical Oncology (ASCO) meeting CME TELEMETRIX ANNOUNCES SENIOR MANAGEMENT CHANGEHemosol Commences Second HemolinkTM Study in the U.S.French Technology Leaders Form Strategic Council for Innovation Rad Bioscience Wins Israel’s Biotechnology Incubator CompetitionEuropean Biotechnology Crossroads presents conference programme AN AMERICAN COATED STENT IN PARIS. CME TELEMETRIX ANNOUNCES SENIOR MANAGEMENT CHANGEBTECH REGULATORY RADAR - Tracking the Movement of Key Products Through Clinical Trials (18 March 02) Setback for Vevesca Approval CAMBRIDGE ANTIBODY TECHNOLOGY AND HUMAN GENOME SCIENCES COMMIT TO EXCLUSIVE DEVELOPMENT OF ANTIBODY TO TRAIL RECEPTOR-2MEDMONITOR - Pearls from the 60th Annual Meeting of the American Academy of Dermatology in New Orleans A Drug to Treat Vitiligo - SWITCH Biotech expands its vitiligo network - cooperation with the Charité in Berlin Btech Weekly Report: Improving Bone Metabolism with Novel Therapeutics HERCEPTIN AND IRESSA WORK TOGETHER IN PRECLINICAL STUDIESPaul Lucas Elected to Board of Directors at Tm Bioscience ALL EYES ON IMCLONE'S FEB 26 FDA MEETINGKS BIOMEDIX EXPLOITING BIOWISDOM’S DISCOVERY INSIGHT SYSTEM IN THE ONCOLOGY AREAFirst Results from Genaissance's Pharmacogenomics Study MEDMONITOR - Pearls from Recent Medical Journals and Conferences 25/2/02 Alzheimer Disease Therapeutics After Betabloc Further proof of concept for targeting ghrelin in the treatment of obesity Btech Investor Reports Weekly: The American Association of Cancer Research Meeting Highlights Labs Highlight Stanford Bioengineering CourseBtech News - IMMUNEX AND AMGEN SYNERGIESTm BIOSCIENCE ANNOUNCES FOURTH QUARTER AND YEAR-END 2001Eprex Versus Aranesp New Edition of The Book of Life, Chapter 20European Formulation of Epo Linked To Pure Red Cell Aplasia BIOCHIPS 2002 - Technology Development & Application and BioChips Ghrelin: The future of obesity therapeutics? Micronic NV. Wide selection of Deep-well refills …Merz and Lundbeck received European Union marketing approval for Ebixa (Memantine) for the treatment of Alzheimers Hormos Medical’s novel male osteoporosis project into clinical trialsPERKINELMER LIFE SCIENCES INTRODUCES THE FIRST DATA AND VISUALIZATION SOFTWARE SOLUTION TO EFFECTIVELY MANAGE ENTIRE GENE EXPRESSION PROCESSLeadDiscovery: Novel targets for breast cancer - Halting tumor progression and pain Vernalis and Roche Cancel Development of Obesity Drug DDB-202: A New Therapeutic Approach in the Treatment of Multiple Sclerosis using Myelin Basic Protein Peptide AnaloguesIBA establishes US Distribution Center PERKINELMER LIFE SCIENCES INTRODUCES NEW PRODUCT PORTFOLIO FOR PROTEIN AND NUCLEIC ACID DETECTIOND.C. BEAT - The Week's Biotech Related News from Capitol Hill (March 19 2002) TKT's Progress At Replacing an Intracellular Enzyme Early Access Program validates LabCD™ technology ... Btech Investor Report: IMPROVING MONOCLONALS - PAYLOAD TECHNOLOGIESAlphaRX Featured on Upcoming Informed Investors Online ForumMolecular Classification of Disease PARADIGM THERAPEUTICS AND GENMAB ANNOUNCE MAJOR ALLIANCE ON DISCOVERY TARGETS FOR HUMAN ANTIBODY THERAPEUTICSRedasoft Launches New Web Site to Help Drive Productivity Improvements in Drug Discovery ResearchBIOWISDOM - DISCOVERYINSIGHT FOR NEUROSCIENCE - ENABLING INVENTION FOR DRUG DISCOVERY PERKINELMER ANNOUNCES FILLWELL BASE MICROPLATE LIQUID HANDLING WORKSTATIONNUNC Silent Screen PlatesBtech News - AMGEN'S NEULASTA APPROVEDTecan's new website goes live ... Completion of flotation on TSX & AIM YM raises c$15 million (gross)AlphaRx Announces Letter of Intent to acquire pharmaceutical manufacturing companyAutoscribe Tracking each stage of a process with full audit trail … Regulatory approval of Exubera by the end of 2002Stocktaking after an exceptional year of co-operation with LEO Pharmaceutical Products Ltd. A/S Exelon Helps Alzheimer Patients Novartis - The NAVIGATOR Study - Frequently asked questionsBtech - MEDMONITOR - Pearls from Recent Medical Journals and Conferences (22/1/02)CAMBRIDGE ANTIBODY TECHNOLOGY COMMENTS ON DEVELOPMENTS REGARDING ITS OFFER TO ACQUIRE ALL OF THE OUTSTANDING COMMON SHARES OF DRUG ROYALTY CORPORATION Btech Weekly Report: New Studies Impact the Rheumatoid Arthritis and Multiple Sclerosis Markets Memantine for Alzheimer Disease BTECH News - GENETIC TESTING FOR NEWBORNS IN CALIFORNIAMyriad Launches Colaris AP Test for Colorectal Cancer Enact Pharma Funding UpdatePlatform Technology vs. Drug Discovery Btech News - Is Amgen Paying Too Much For Immunex?INTERLEUKIN LAUNCHES A PHARMACOGENOMICS STUDY OF RHEUMATOID ARTHRITIS Avonex Is Not an Orphan Any More BTECH REGULATORY RADAR - Tracking the Movement of Key Products Through Clinical TrialsBTECH REGULATORY RADAR - Tracking the Movement of Key Products Through Clinical Trials (19/2/02)COATED STENTS PERFORMING WELL IN TRIALSKetek Can Treat Drug-Resistant Respiratory Tract Infections Key Organics Joins Proteom in Prolysis' Drug Discovery Program PERKINELMER LIFE SCIENCES DISCLOSES DETAILS OF NEW PROTEINARRAY WORKSTATIONBtech News - Benefits of Angiomax and RefludanBiogen Receives Complete Response Letter For Amevive A Statin A Day Keeps the Doctor Away Btech Investor Reports Weekly: Some Silver Linings to a Cloudy Week BTECH NEWS - MEDMONITOR - Pearls from Recent Medical Journals and ConferencesCambridge Biotechnology Ltd (CBT) has secured a £6 million series 'A' financing Btech Weekly Report: Scientific Advances In RNA Interference and Cloning Myriad to Sequence Plants for DuPont BTECH NEWS - IMCLONE'S ERBITUX - A CASE OF NOT MANAGING EXPECATIONSXOLAIR HELPS PEOPLE WITH HAY FEVERExpansion of Statins and NSAIDs to Alzheimer Treatment Borean Pharma Granted United States Patent for Lead Therapeutic Candidate for Atherosclerosis BTECH REGULATORY RADAR - Tracking the Movement of Key Products Through Clinical Trials (11/2/02)Neotrofin Not Efficacious In The Treatment of Alzheimer Disease Cellomics - New software suite enhances cellular-based drug discovery … Central Nervous System Report 2002New Amino Acid Analyser AAA for Montreal Children’s HospitalMitoKor's initial public offering (IPO) A Glimmer of Hope for Neotrofin Positive Data from Daiichi CATALYST: Roche is finding it difficult to manufacture its novel antiretroviral drug T-20Euromobility The Trend for Life Sciences Workforces of the Future? BTECH WEEKLY REPORT: THE MOUSE GENOME REVEALED Molecular Devices Introduces New 96/384-Well DispenserCubist's (NASDAQ: CBST) investigational antibiotic Cidecin (daptomycin for injection) challenges Cipro CARDIOME ACQUIRES CLINICAL PROGRAM - Gout Program Builds on Congestive Heart FailureARCHEMIX APPOINTS STEVEN HOLTZMAN TO BOARD OF DIRECTORSCelgene Needs a Phase III Trial IGENEON LICENSES HUMANIZED ANTIBODY IN CANCER FROM PROTEIN DESIGN LABS Schering Offers To Buy the Rest of Collateral New Anti-Amyloid Contructs Will Replace Betabloc The FDA Will Re-Examine Bexxar ARAKIS CLOSES £16 MILLION SECOND ROUND FINANCING Tracking the Movement of Key Products Through Clinical Trials (15 Jan 2002)MEDMONITOR - Pearls from Recent Medical Journals and Conferences (4 Mar 02) RiboTargets Wins Top Safety AwardBtech News - D.C. BEAT - The Week's Biotech Related News from Capitol Hill (28/1/02)Advances In Pharmacogenomics ProjectsBtech Weekly Report: Shaking Up The U.S. Multiple Sclerosis Prestigious Award for Innate Pharma's David Raulet NYXIS NEUROTHERAPIES ANNOUNCES POSITIVE PRE-CLINICAL RESULTS FOR NT-13 IN LEARNING, NEUROPATHIC PAIN AND STROKE WITH NO OBSERVED TOXIC OR ADVERSE SIDE EFFECTSThe Automation Partnership Launches New Cell Culture System at MipTecBtech Investor Inc - News archiveHemosol Receives Key U.S. Patent Approval Rebif Beats Avonex In Head-To-Head Trial New Nitric Oxide Therapeutics RiboTargets Receives Exclusive License to 30S Ribosome PatentsBTech News - MEDMONITORBTECH WEEKLY REPORT: CLINICAL TRIALS NEED PHARMACOGENOMICS Vardenafil Approvable World's Largest Biomanufacturing Facility For Seed Potato To Be Built In Wisconsin D.C. BEAT - The Week's Biotech Related News from Capitol Hill (12/2/02)The Automation Partnership Appoints French Key Account ManagerHitting cancer where it hurts - Mixed opioid/somatostatin ligands as tomorrow's anti-cancer target? Integra BioSciences Safe aspiration of laboratory samples ... Monoclonal Antibodies are Not Always Better We are happy to announce Bioportfolio.com has partnered with VerticalNet to offer you access to a NEW Supplier Directory on our web site.Show Off Your Best Image In the Bio-Rad Laser Scanning Microscopy Image CompetitionDon't Miss the European Microscopy & Imaging Event of the YearPERKINELMER LIFE SCIENCES DISCLOSES DETAILS OF NEW PROTEINARRAY WORKSTATIONBtech News - D. C. BEAT - GAO Study Presents Opportunity for Pharmaceutical CompaniesCampath Improves Survival of Refractory CLL Patients Kirchhoff Consult AG (DE) - Royalty Pharma AG decides not to proceed with its initial public offering on SWX Swiss ExchangeTreating Erectile Dysfunction CME TELEMETRIX ANNOUNCES NON-INVASIVE MEASUREMENT CAPABILITY FOR HbA1c AT ANNUAL MEETING OF SHAREHOLDERSINTEGRA Biosciences Group has announced a new 24-well F-bottom plate - New, unique 3-D microenvironment promotes cell growth Laser Scanning Microscopy Experts at MICROSCIENCE 2002Capsulution NanoScience AG Federal Research Ministry supports Nanotechnology Positive Results from AACR in San Francisco CME TELEMETRIX TEMPORARILY WITHDRAWS COMPLAINT OF PATENT INFRINGEMENTMEDMONITOR - Pearls from Recent Medical Journals and Conferences (2/4/02)Seattle Genetics Partners With Genentech Capsulution NanoScience AG Development Agreement with a Global PlayerCambridge Antibody Technology and Xerion Pharmaceuticals Enter Research CollaborationTreating Erectile Dysfunction CME TELEMETRIX ANNOUNCES SUBSTANTIAL PROGRESS IN NON-INVASIVE GLUCOSE MONITORING DEVICE ACCURACYCytomyx signs major new contract with m-phasys Btech News - NEUROCRINE WANTS YOU TO SLEEP WELLTm Bioscience to Hold Annual General Meeting of Shareholders Collaboration between RiboTargets, The Institute of Cancer Research and Cancer Research Ventures Btech News - ERBITUX APPROVAL DELAYED BUT STILL EXPECTEDBtech News - MEDMONITOR - Pearls from Recent Medical Journals and ConferencesBTECH REGULATORY RADAR - Tracking the Movement of Key Products Through Clinical Trials 25/2/02 Matrix metaloproteinase (MMP)-9: A target for COPD and cancer ImClone Must Decide Whether To Start New Trials American Society of Clinical Oncology's 38th Annual Meeting Bad News for Corixa Tm Bioscience Develops Array Based Cystic Fibrosis Test BALANCING RISKS AND BENEFITS OF LIGAND'S ONTAK FOR PSORIASIS PATIENTSCAMBRIDGE ANTIBODY TECHNOLOGY AND HUMAN GENOME SCIENCES ANNOUNCE SECOND DRUG PARTNERSHIPBtech Investor Reports Weekly: Coated Stents in the Spotlight The Bexxar Saga Continues KREATECH Licenses ULS Technology to PerkinElmer Life Sciences Histone deacetylase inhibitors: Redefining pharmaceutical approaches to the treatment of cancer 2nd Annual RETINAL DISEASE AND GLAUCOMA - New Therapeutic Strategies Hormos Medical Corp. EUR 18.4m BankInvest, H & B Capital, Sitra, Bio FundALGORX COMPLETES ACQUISITION OF LATE STAGE PAIN PRODUCT AND LICENSE TO DRUG APPLICATIONS OF TECHNOLOGY PLATFORM FROM POWDERJECTCAMBRIDGE ANTIBODY TECHNOLOGY (CAT) AND DRUG ROYALTY CORPORATION (DRC)Recommendations Should Lead to Increased Aranesp and Neulasta sales in Europe Nanosphere Signs Letter of Intent with Takara Bio Inc. to Form Development and Distribution Alliance Btech weekly report: Therapies for rheumatoid arthritis and psoriasis COPD: Smoking out tomorrow's therapies for emphysema and chronic bronchitis Micronic NV. Society for Biomolecular Screening new productBioPortfolio BioNews (News & Press Releases)PerkinElmer Life Sciences and NextGen Sciences Partner in Fast-track Development of the First Fully Automated System for Processing Protein MicroarraysDANIOLABS RAISES £850k IN SEED FUNDING TO ACCELERATE ITS DRUG DISCOVERY PROCESS Btech News - Towards Successful Stem Cell TherapyPress release for immediate releaseBtech News - A TASTE OF PHARMACOGENOMICSPowderMed's DNA-based Flu Vaccine Shows Cross Protective Immunity Against Genetically Drifted Flu Strains, Offering Potential for Vaccine Effective Against Emerging Flu Variants BTECH NEWS - ABGENIX CANCELS DEVELOPMENT OF ABX-IL8 FOR RHEUMATOID ARTHRITISAlphaRX Announces Commercialization of LipoBloc(TM) and LipoLette(TM)Is Pure Red-Cell Aplasia Linked to All Epo Products or Just Eprex?Interactive Voice Response (IVR) Technology Adds Value to Clinical TrialsNew Trials for Insomnia, Diabetes, and Crohn Disease PARADIGM THERAPEUTICS ANNOUNCES AWARD OF THREE GRANTS TO SUPPORT ITS RESEARCH ON CANCER, CNS DISEASES AND HORMONE DISCOVERYAnalytiCon Discovery appoints top-class Scientific Advisory Board Redasoft, SoftHome International Sign Distribution Agreement for Visual Cloning Software in TaiwanBiowisdom announce membership of distinguished scientific advisory board Btech News - ANTISENSE MAKES SENSE TO AMGENCrimson Medical Is Now MDD 93/42/EEC CompliantNUNC The Art of Cell Culture NUNC Flasks on a SlidePerkinElmer Introduces First ultraHTS Reader for Fluorescence Polarisation (FP) AssaysNext generation microplate reader … AVI'S Antisense Construct Influences Metabolism of Buspar ALRX News - Alpha Rx Secures Private Placemenrt FinancingAmerican Society of Clinical Oncology meeting day 3 PERKINELMER LIFE SCIENCES AND THE INTERNATIONAL RICE RESEARCH INSTITUTE BTECH REGULATORY RADAR - Tracking the Movement of Key Products Through Clinical Trials (22/1/02)Revolutionary technology to reduce the complexity of the proteome COURT ISSUES FORMAL RULING CONFIRMING DECISION ON GRIFFITHS PATENT Statins for Alzheimer Disease ALRX - News, AlphaRx Announces Share ConsolidationExtended Use of Lovenox May Extend Sales SWITCH Biotech strengthens its business development Enact Pharma/ De Montfort Biopharma LEADING THE WAY TO COMBAT CANCER AND DEGENERATIVE BRAIN DISEASESBtech News - The Issue of High Prescription Drug Prices is Beginning to Regain Political SteamMEDMONITOR - Pearls from Recent Medical Journals and Conferences (11 March 2002) Highlights of the American Diabetes Association Meeting Hemosol Announces Full Year 2001 Financial ResultsEnact Pharma Appoints Dr. Richard Goodfellow as a Non-Executive DirectorOntogen Discovery Systems Presents OntoCHROM(R) Superiority Over Conventional Compound Purification SystemsBETABLOC DOSING SUSPENDEDNatrecor On The Road to Becoming a Blockbuster Study Supports Target Validation in Lower Organisms Commercializing on Tumor Antigens - The Next Wave? - New "de-novo" analysis from BioSeeker GroupEZ Solvent evaporation … Btech News - ARANESP SALES SHOULD ACCELERATEPralnacasan Results Strong Enough To Move Forward Increasing sales for Porvair Sciences in 2002 …D.C. BEAT - The Week's Biotech Related News from Capitol Hill (19/2/02)BTECH WEEKLY REPORT: THALIDOMIDE, STATINS, AND ANGIOMAX Positive Results for the CAT-152 Monoclonal Antibody BioNewsCast Press Release Service 2004 Archive BioNewsCast Press Release Service 2003 Archive BioNewsCast Press Release Service 2002 Archive
Have your press releases posted here?
BioNewsCast Press Release Service 2004 Archive
BioNewsCast Press Release Service 2003 Archive
BioNewsCast Press Release Service 2002 Archive
Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.
All rights reserved. All other trademarks recognized. Copyright © 1997-2009 - BioPortfolio Limited.
